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Abstract 
 
The vertebrate filamin family (A, B, and C) are critically involved in development of brain 
structure, cardio-vasculature, and skeleton. Filamins are large F-actin cross-linking proteins 
containing an actin-binding domain, followed by 24 Immunoglobulin(Ig)-like domains. 
Filamins play critical cellular roles as mechanical and scaffold proteins. As mechanical 
proteins they cross-link F-actin into gels or fibrils. As scaffold proteins they bind over 70 
critical proteins. Filamins have overlapping and distinct roles, however it is not understood 
why. Nor well understood, are the mechanisms by which filamin act as mechanical proteins. 
Our work focuses on understanding their function; by analyzing site-specific functional 
divergence, using the evolutionary trace (ET) method, over vertebrate developmental periods 
—– Teleostei, Amphibian, and Mammalian; and by analyzing filamin behavior under 
mechanical stress. We find, isoforms diverge from one gene between urochordate and 
vertebrate lineages; most divergence occurs in Teleostei; and that filamin C diverged least. In 
addition, the heterogeneous spatial pattern of functional divergence we observe is not 
correlated with scaffold protein activity either in binding interfaces or across domains. Our 
results also suggest isoforms have diverged with regard to specificity for binding partners or 
regulatory function. To elucidate the structure-function relationship of filamin, we used 
constant force (0-315 pN) simulations to derive both the critical unfolding force and the 
unfolding pathways at biological levels of force (35-70 pN). Despite a large heterogeneity in 
 iii 
the population of force-induced intermediate states, we find a common initial unfolding 
intermediate in all the Ig-like domains of filamin, where the N-terminal β strand unfolds. We 
also study the simulated thermal unfolding of several filamin Ig-like domains. We find that 
thermally-induced unfolding has an early-stage intermediate state similar to the one observed 
in force-induced unfolding and characterized by the N-terminal strand being unfurled. We 
propose that the N-terminal strand may act as a conformational switch that unfolds under 
physiological forces leading to exposure of cryptic binding sites, removal of native binding 
sites, and modulating the quaternary structure of domains.  This work provides insights into 
both isoform distinctive and mechanical properties of vertebrate filamin. 
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Chapter 1 
The filamin family of proteins  
The vertebrate filamin family (A, B, and C) are critically involved in development of 
brain structure, cardio-vasculature, and skeleton. Filamins play critical cellular roles as 
mechanical and scaffold proteins. As mechanical proteins they cross-link F-actin into gels or 
fibrils. As scaffold proteins they bind over 70 critical proteins. Filamins have overlapping 
and distinct roles, however it is not understood why. Nor well understood, are the 
mechanisms by which filamins act as mechanical proteins. This work addresses these 
questions. 
 
1.1 Background 
 All vertebrate filamin family members are architecturally composed of an N-
terminal actin-binding domain (ABD) followed by a series of 24, ~96 residue 
Immunoglobulin(Ig)-like domains (Figure 1.1). The 24th domain is the self-association 
domain giving a filamin dimer the ability to cross-link F-actin. Invertebrate filamin that have 
fewer domains exist. For example, the single homologous fly filamin has an ABD followed 
by only 20 Ig-like domains (6); and the single Dictyostelium discoidiem filamin (ddFilamin) 
has an ABD, but is followed by only six Ig-like domains (Table 1) (7). All family members 
have been associated with mechanical roles such as cellular motility, cell morphology, and 
involvement in stress areas of cells (8-11). In addition, family members act as scaffold 
proteins and are involved in many critical signaling pathways including inside-out and 
outside-in signaling. Signaling also results in cytoskeletal rearrangements associated with 
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cell motility and cell morphology modulation (12-14). Thus, filamins are a structural protein 
and are also involved in signaling structural changes within a cell. 
The N-terminal ABD gives filamin a mechanism for both binding actin, and 
regulating this interaction. The ABD consists of two calponin-homology (CH) domains 
connected by a negatively charged linker. CH domains are ball-like, consisting of seven 
alpha helices. CH 1 has two putative actin-binding sites, and CH 1 has been shown to directly 
bind F-actin (15). CH 2 has one putative actin-binding site, and CH 2 is believed to play a 
regulatory role in binding F-actin. The interaction of filamin with calmodulin on CH 1 is 
reported to also regulate its interaction with F-actin (2). However, the role of CH 2 is less 
well understood. Several missense mutations in CH 2 of both filamin A and B cause a 
spectrum of similar skeletal disorders. These mutations are believed to enhance binding to F-
actin (170), and have been considered gain-of-function mutations (17). However, the 
function of CH 2 is not well understood.  
 
 Ig-like domains give filamin their strength and long reach. Ig-like domains are β 
sandwich structures consisting of seven β strands (A-G) (Figure 1.2). The two terminal edges 
 
Figure 1.1. Filamin family of proteins.  Models of vertebrate filamin A, B, and C showing their Ig-like 
and calponin homology domains; and regions rod 1 and rod 2. D. discoidiem is an invertebrate filamin 
having only six Ig-like domains. 
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of Ig-like domains are composed of β strands AG and CD. Each Ig-like domain is able to 
withstand large forces (50-220 pN) (16). The ability to withstand force, along with the 
overall domain architecture, is associated with giving cells their rheological properties (17). 
A filamin dimer can be extended end-to-end over 160 nm (18). The long extension comes 
from the linear arrangement of Ig-like domains in rod regions.  An elongated series of 15 Ig-
like domains, connected by short linkers, make up the first rod region. A hinge (H1) (> 30 
aa) connects rod 1 to a second rod region giving filamin high flexibility (19). Rod 2 is more 
compact and made up of Ig-like domains 16 and above. A second hinge (H2) connects 
domain 23 to the dimerization domain, 24 (20). Ig-like domains also allow filamins to act as 
scaffold proteins. Most binding partners occur though interaction on rod 2, and binding 
isolated to the CD face. The reasons for these specificities are not understood. 
 
 The diversity of vertebrate filamin is increased by alternate splice-variants (21) that 
have differing structural roles in cells. Internal insertions and deletions in filamin isoforms 
vary by tissue type and development stage. While H2 exists in all filamin isoforms, H1 is 
 
 
 
Figure 1.2. Filamin Ig-like domain.  This domain 
consists of a seven-stranded β sandwich structure labeled 
A-G, with β strands AG located on faces opposite to CD.  
Both β strands A and G are bisected, having components 
A, A’, G’, and G respectively. 
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absent in some forms of filamin B (ΔH1) and all forms of Filamin C. In filamin A and B 
there is a deletion of 41 residues in the last β strand of domain 19 and the first two β strands 
of domain 20 (ΔVar1)(21). These two variants are widely expressed at low levels. Filamin C 
has an insertion of ~80 residues at the end of β strand A in domain 20, which is associated 
with its localization in muscle.  
 Filamins play a dual role, functioning as both mechanical and scaffold proteins. As 
mechanical proteins they cross-link F-actin into gels and fibrils. As scaffold proteins they 
bind over 70 critical proteins, including transmembrane proteins as well as proteins involved 
in trafficking, signaling, F-actin remodeling, and transcription (Table 1).  
 
Figure 1.3. The role of filamin in a cell.  Filamin (purple) cross-
links actin (blue) into orthogonal gels and fibers.  It also is a 
scaffold interacting with many transmembrane proteins (red) 
including integrins (orange) which interact with the extracellular 
matrix (ECM-black/gray).  Filamin also interacts with cytosolic 
effector proteins (red). 
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Filamin-associated function Reference 
Outside-in signaling (22-25) 
Ion channels (26, 27) 
Vesicle trafficking (28) 
Endocytosis (29-31) 
Soluble receptor (32-34) 
Transcription factor (35, 36) 
Cytokinesis (37, 38) 
Muscle regeneration (39, 40) 
Muscle contractile (41, 42, 43 ) 
Cellular adhesion (2, 5, 44-50) 
Actin remodeling (51-53) 
Differentiation (21, 54-57) 
Mechanoprotection (58-61) 
 
 
1.1.1 Filamins as mechanical proteins 
Filamin is one of the most potent F-actin cross-linkers. In vitro, at low concentration, 
filamin produces the same sized F-actin structures as other F-actin cross-linking proteins do 
at much higher concentrations (15). At low concentrations filamin and F-actin produce gels, 
but at higher concentration they produce bundles. In vitro, gels have rheological properties 
similar to those of cells (17). A recent hypothesis suggests that filamin not only cross-links F-
actin, but also acts in cells as a template to polymerize actin into orthogonal interconnects. 
This hypothesis comes from recent work which shows that filamin has a secondary site of 
actin binding in N-terminal domains; and as a dimer, filamin monomers have relative 
orientation of ~90° degrees (18, 62).  
Heterologous filamin-null cells suggest a critical role for filamin A in morphology. In 
situ, melanoma cells with diminished levels of filamin A (M2 cells) have defects in motility, 
Table 1. Filamin-associated function 
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cell shape, and membrane blebbing. Also, filamin A is critical to the disc morphology of 
resting platelets (63). Recently, primary filamin B-null mutant fibroblasts were shown to 
have significantly impaired motility (64). Similarly, filamin C-null mutant myocytes have an 
aberrantly rounded phenotype (65). Thus, it has been postulated that all filamin isoforms play 
critical structural roles. 
As mechanical proteins, filamins play important roles in cell structure in vivo. 
Different isoforms express in distinct tissue. Filamin A and B are ubiquitously expressed and 
filamin C is expresses in muscle. All isoforms are localized to stress areas of cells. Non-
muscle filamin localization includes the leading edge of motile cells (66) and stress fibers 
(67, 68). Filamin C is localized to the Z-disc of myotubes (39). Splice-variants cause 
variations in subcellular localization. For example, the filamin B H1-ΔVar1 splice-variant 
exclusively localizes to the tips of stress fibers in developing muscle cells (21).  
  
 1.1.2 Filamins as scaffold proteins 
 Actin-filamin gels are localized to the submembranous cortex of a cell, where 
filamins act as scaffold proteins by linking transmembrane proteins to downstream signaling 
cascades (25). Filamins bind to a diverse set of proteins (Figure 1.3) (4, 69). These include 
actin remodeling associated proteins and their effectors including GTPases (Rac, Rho, 
Cdc42, and RalA), GTPase-activation proteins (e.g., FILGAP) and GTPase exchange factors 
(trio) (51, 53, 70). GTPases have been implicated in many aspects of cell physiology, 
including proliferation, differentiation, cytoskeletal organization, and vesicle trafficking(71-
73). GTPases are also emerging as important molecules in cellular response to exogenous 
and intracellular force by coordination of cytoskeletal rearrangements and gene expression 
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(74, 75). Other binding partners include G-protein coupled receptors (e.g. dopamine D2 
receptor) (25), ion channels (e.g. cystic fibrosis transmembrane conductance regulator) (27), 
transcription factors(e.g., MEKK4)(35), kinases (e.g., cAMP-dependent protein kinase 
(PKA)) (76-80), phosphatases (e.g., PEST-motif containing protein tyrosine phosphatase) 
(38, 81), vesicle trafficking associate proteins (e.g., BIG2)(28), and proteases (e.g., calpain) 
(82-84).  
Filamin A has been shown to mediate protein trafficking (27, 82) and protein 
localization (23), and it may create signaling subdomains on the plasma membrane (85). 
Filamins also bind adhesion proteins, including β1 integrin family members B1A, B2, B3, and 
B7 (21, 47, 86), and the GPIbα subunit of the von Willebrand receptor (87-89). The 
interaction of filamin with adhesion proteins is associated with cytoskeleton anchoring (90). 
Adhesion proteins may also localize filamin in cells (21). 
    
Filamin is both a substrate and binding partner to several kinases. For example, 
PKCα is believed to bind to both the N- and C-terminus domains of filamin and has activity 
 
Figure 1.4. Filamin as a scaffold protein (4).  As a scaffold protein, filamin interacts with 
transmembrane proteins, such as receptors and ion channels.  Filamin also interacts effector 
proteins such as kinases and GTPases. Most proteins interact with filamin on domains 16 
and above.  Binding partners bind specific Ig-like domains; for example, the two best-
characterized domains are domain 17 binding to the von Willebrand receptor subunit GPIβα 
(2), and β1 integrin family members binding domain 21 (5).    
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on the C-terminus region (78). Phosphorylation of filamin is important for its activity, 
including migration and actin reorganization (79). Many other kinases phosphorylate filamin 
in vitro, including cyclic Ribosomal S6 Kinase, PKA, and CaM kinase II(79). Filamins are 
also phosphorylated in vivo (91, 92). Sites that are phosphorylated range the entire length of 
the protein (91, 92).  
 With the exception of kinases, the binding partners of filamin bind almost exclusively 
to specific Ig-like domains in rod 2 (Figure 1.4). Additionally, a generalized binding 
mechanism has been identified as β sheet extension of β strand C (2, 5, 49, 93). Many of the 
binding partners of filamin have been found in interaction assays with Filamin A. It is not 
known to what extent these binding partners also bind to filamin B or C.  
 
1.1.3 Filamin as both scaffold and mechanical proteins 
Several reports suggest that filamin acts as both a scaffold and a mechanical protein 
in several stress pathways. These include mechanoprotection (58, 61), extracellular matrix 
(ECM) compliance matching (57), and cell-fate determination (55, 94). 
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Mechanoprotection is the process by which cells reinforce their cytoskeleton in 
response to high tensile exogenous force. Several investigators showed that filamin A 
accumulates at cell adhesion sites in response to mechanical tension, suggesting a role for 
filamin A in mechanoprotection (58, 95). Shifrin et al. showed that FILGAP is targeted to 
filamin A in response to exogenous force applied through β1 integrins (61). There, FILGAP 
deactivates Rac, leading to mechanoprotection. 
Another stress related pathway associated with filamin is ECM compliance matching 
(Figure 1.5). This is the process by which cells match internal stress with ECM stiffness. 
Gehler et al. showed that filamin A acts as a stress sensor in ECM compliance matching 
through a feedback loop that matches extracellular stiffness with intracellular stress. They 
further showed that filamin A is the structural linkage connecting ECM-bound integrins to 
acromyosin contractility (57). It has been suggested that involvement of filamin in ECM 
 
 
Figure 1.5. ECM compliance matching(3). Extracellular matrix (ECM) stiffness 
is matched to intercellular stress by acromyosin motor proteins that that pull on 
actin.  F-actin is connected to scaffolding proteins that are connected to cell 
adhesion proteins.   
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compliance matching is related to its scaffold activity, since Filamin A binds GTPase effector 
proteins that regulate acromyosin contractility (53). Furthermore, Filamin A is reported to 
regulate myosin-mediated contractility in vitro (96, 97).  
ECM compliance matching is also a mechanism by which cells use environmental 
cues to mediate differentiation (98). The role of filamin in ECM compliance matching 
associated with differentiation could be related to its scaffold activity, since filamin binds 
several transcription effector proteins (e.g. androgen receptor(32, 33), SMADS(35))  as well 
as mitogen-associated kinases(80). Furthermore, filamin has been shown to play a critical 
role in differentiation of breast epithelial cells (filamin A) (57) and maturation of 
chondrocytes (filamin B) (55). Thus, filamin is believed to be involved in the pathways 
involving both extracellular and intracellular stress, and the relationship of filamin with 
scaffold proteins likely regulates transcriptional activity associated with differentiation. 
 The mechanism by which filamin operates in stress pathways is not yet identified. One 
hypothesis is that filamin activity is indirectly mediated during stress pathways.  In this 
scenario, stretch-activated calcium channels mediate intracellular calcium levels (99).  
Calcium levels then mediate both the filamin turnover (78, 100) and F-actin binding (56, 81, 
100, 101).  
 Other studies suggest that the role of filamin A as a scaffold protein is modulated by 
the quaternary structure of its rod 2 region (93). For example, the crystal structure of domains 
19-21 reveals domain-domain interactions resulting in the auto-inhibition of β1 integrin 
binding (93). It is believed that stress may regulate the quaternary structure of these domains, 
resulting in enhanced binding of integrins. 
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1.1.4 The role of filamin in vivo 
Accumulated evidence suggests a critical role for filamin in cells (12, 17, 102). 
However, most filamin-null mutant cells from knockout animals appear unaffected by loss of 
filamin (55, 64, 65, 103-105). Since filamins are highly similar, it is suspected that they have 
overlapping roles. However, the phenotypes of these knockout animals are considerably 
different. Filamin A knockout mice have midline defects (103, 104), disorganized heart and 
endothelial cell gap junction defects, and they die prematurely of bleeding. Filamin B 
knockout mice have, both microvasculature and skeletal defects, linked to chondrocyte 
maturation defects (55, 64, 105). Filamin C knockout mice have lethal muscle defects (65).  
 Furthermore, disease-causing filamin mutations suggest that isoforms have both 
overlapping and distinct functions (Table 2). Loss-of-function mutations in filamin A result 
in periventricular nodular heterotopia (PV) (106). Both loss-of-function mutations in filamin 
B (36, 105) and surface exposed missense mutations in many domains of filamin A and B 
lead to a spectrum of similar skeletal disorders (107, 108). Deletion of the last 8 C-terminal 
residues in filamin C leads to late-onset muscular dystrophy (43, 109). Loss of filamin and 
hence loss of scaffolding of interacting partners (SMADS, BIG2) has been suggested as 
critical by other studies (28, 36, 110). From these studies we conclude that filamin A is 
critical to heart, brain, and bone development; filamin B is critical to developing 
chondrocytes; and filamin C is critical to the function of muscle. However, filamin-
associated disease mutations in N-terminal domains, and lack of binding partners in those 
domains suggest that there is much more to be understood about the function of this protein 
family. 
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Name I Typical manifestation  OMIM 
Periventricular 
nodular heterotopia 
(PV) 
A Male lethal, Nodules on lateral ventricle of 
cerebral cortex containing late stage neurons 
that failed to migrate radially 
300049 
Otopalatodigital 
syndrome types 1 
(OPD1) 
A Deafness, cleft palate, facial malformations, 
wide thumbs, long metacarpals, severe 
scoliosis, and dislocations of the hip and knee 
311300 
Otopalatodigital 
syndrome types 2 
(OPD2) 
A OPD2 more severe then OPD1.Microcephaly, 
retardation, malformed skull, ribs, clavicles, 
scapula, pelvis, curved long bones  
304120 
Frontometaphyseal 
dysplasia (FMD) 
A Overgrowth of frontal facial bone 305620 
Melnik-Needles 
syndrome (MNS) 
A Malformed skull, craniofacial structures, 
irregular ribs, deformed clavicles, scapula, 
pelvis, and curved long bones  
309845 
Prolapsed valve A Myxomatous degeneration of cardiac valves  
Chronic idiopathic 
intestinal pseudo-
obstruction (CIP) 
A Intestinal obstruction without any mechanical 
lesion 
300048 
 Bernard-Soulier 
syndrome (BSS) 
A Excessive bleeding and large fragile platelets 131200 
spondylocarpotarsal 
synostosis (SCT) 
B Disproportionate short stature, scoliosis and 
lordosis, carpal and tarsal fusion, hearing loss, 
midline cleft palate 
272460 
Larsen syndrome 
(LS) 
B Dislocations of the hip, knee, and elbow; 
scoliosis and cervical kyphosis; prominent 
forehead, midline cleft palate, and hearing loss 
150250 
Atelosteogenesis 
types I (AOI) 
B Short-limbed dwarfism, LS dislocations, and 
lethal 
108720 
Atelosteogenesis 
types I (AOIII) 
B Short-limbed dwarfism, LS dislocations 108721 
Boomerang 
dysplasia (BD) 
B Dwarfism, short, bowed, rigid limbs, lower 
spine, ossification, and digits retarded 
112310 
Filaminopathy C Late-onset muscular dystrophy 609524 
Table 2. Diseases associated with filamin isoforms (I) 
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1.2 Isolation of filamin function using evolution 
 Much of our accumulated knowledge about the function of filamin is derived from 
using the yeast two-hybrid screen that identifies filamin interaction with a subject protein. 
Functional analysis is usually performed in melanoma cells, which lack filamin A.  
Unfortunately the limitations of current methods, in our opinion, have led to a biased 
sampling of interacting partners and a bias towards C-terminal binding. Some evidence for 
these biases is suggested by the presence of kinase activity and a number of disease-causing 
mutations in filamin rod 1 but the general absence of binding partners there. In addition, 
cancer cell lines have regulatory defects in GTPase signaling, resulting in aberrant 
locomotion and morphology (111).  
 To avoid the current biases in filamin research, it is important to use a top-down 
approach to understand the function of filamin. Based on vertebrate isoform similarities in 
sequence and function, we hypothesize that filamin isoforms have diverged from a common 
ancestor, and those isoforms have maintained shared function, developed new function, or 
modified existing function. Therefore, it is possible to understand the function of individual 
filamin isoforms by analyzing site-specific divergence within the filamin family of proteins. 
 
1.2.1 Analyzing functional divergence  
 Two distinct methods, evolutionary rate-based and evolutionary trace (ET), have been 
developed to derive functional significance from evolution of protein families (112). Both 
methods depend upon first deriving the common ancestor, then reconstructing all ancestral 
filamin forms at clade branch points of the phylogenetic family tree. The rate-based methods 
discriminate functional vs. non-functional sites by assessing site-specific rate shifts between 
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different subsets of homologous genes. For example, a site would be considered functionally 
informative if it were stable in one isoform but variable in another. A rate-based approach 
has been used on Src homology domains (113-115). Since the rate-based approach depends 
upon the resolving power of statistical tests, it is not well suited for small families such as 
filamin. 
 
1.2.2 Evolutionary trace 
 The evolutionary trace (ET) method discriminates functional vs. non-functional sites by 
screening for site-specific change in amino acid biophysical properties. Since conserved 
function is usually associated with conserved biophysical properties at particular sites, a shift 
in residue biophysical property is usually associated with a shift in function. Function could 
be related to a modulation of a protein-protein interface or a structural change. Additionally, 
a biochemical shift could occur by chance if the residue is functionally unconstrained. The 
ET method can distinguish functional vs. nonfunctional shifts based upon rate of change by 
assuming that functionally unconstrained residues have a higher observed mutational rate. A 
biochemical shift in a particular clade is also referred to as either a  “class-distinctive” or  
“distinctive “ change. ET has been used on protein families, including TGF-β(116), GPCRs 
(117), and norovirus viral capsid (118). Often an ET is used in combination with a protein 
structural to provide a spatial context for analyzing functional divergence. 
 In this work we use a highly constrained ET method (Figure 1.6) to increase the power 
to discriminate functional vs. non-functional sites. In our implementation of the ET method 
we exclude from analysis those sites that are not functionally constrained throughout 
evolution. We also exclude residues if they show signs of being functionally unconstrained 
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due to high variability. Thus, in our implementation of the ET method we try to elucidate 
only functionally informative sites. We also improve upon traditional ET methods by 
excluding highly variable sites, whose functionality is indeterminate. 
  
1.2.3 Results from evolutionary trace 
Functional divergence:  To study functional divergence of filamin, we performed a 
phylogenetic analysis of invertebrate, invertebrate chordate, and vertebrate filamin using 
Bayesian methods. Then we used ancestral reconstruction to derive ancestors at clade branch 
 
Figure 1.6. Evolutionary trace method.   In the evolutionary trace method ancestors are reconstructed at 
clade branch points.  Then specific sites are traced from the common ancestor to human.  If there is no 
change in residue type (site 451) then the site is considered “ancestral.” If there is a change in residue type 
(site 456) and it becomes fixed in a particular isoform, we call this a “distinct” residue in an isoform.  Note 
we require that one isoform remains ancestral for the site to be considered functional. 
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points of the phylogenetic tree. We used these ancestors to perform our highly constrained 
ET method. In addition, as part of the ET analysis, we also recorded the period (Teleostei, 
Amphibian, or Mammalian) in which distinctive divergence of a site in an isoform occurred 
so that we could discriminate early vs. late divergence. We also examined well-characterized 
domains associated with critical filamin function, the ABD, and Ig domains 17 and 21.  
Subsequently, we derived an all-atom homology model of filamin A to provide a 
spatial and temporal context for functional divergence. Our homology model of a filamin A 
monomer was created as a sum of its parts. We first derived all-atom homology models for 
individual domains using structural templates from homologous Ig-like domain. Then we 
connected domains using the relative orientation of a pair of ddFilamin Ig domains as a 
guide. We then mapped onto the structure both conserved and distinctive divergent residues, 
including an indication of period (Teleostei, Amphibian, or Mammalian) in which divergence 
occurred. We also analyzed the structure for functional subdomains by observing large 
regions that have not diverged from the common ancestor or have diverged in just one 
residue. 
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Structure: During homology modeling we identified two types of Ig-like domains, six β 
stranded and seven β stranded. The latter forms the rod I region as a linear arrangement of 
domains. The six β stranded domains we identified are domains 18 and 20, which cause rod 2 
to form a compact region. The resultant hormonology model is very similar in size and 
features to low resolution electron micrographs, including the compact C-terminal region. 
Phylogeny: The filamin family diverged from a common single ancestral gene between 
urochordate and vertebrate lineages. Filamin isoforms diverged the most during early 
vertebrate evolution in the period prior to the branching of the Teleostei lineage off the 
Chordate phylogenetic tree. Filamin C diverged the least from the common ancestor.  
Evolutionary trace: From current reports, most filamin functionality is attributed to rod 2, 
but we did not observe a significant difference between rod 1 and rod 2 with regard to 
functional divergence. In our examination of well-characterized domains, ABD and Ig 
domains 17 and 21, we found that although these domains are highly conserved, there are 
subdomains that have distinctive changes, suggesting that isoforms have diverged with 
regard to specificity for binding partners or regulatory function. We also observed the 
potential for regulatory differences among isoforms, since 34% of functionally divergent 
changes involve a change to or from a serine residue in filamin A and C, but only 11% of 
such changes in filamin B. There appeared to be a quiescence of divergence towards C-
terminal domains of rod 2 (filamin A 21-24), suggesting the possibility that binding 
interactions in these domains predate vertebrate evolution (integrins for example). Some 
isoforms have significantly more distinctive residues in some domains than others (e.g. 
filamin B domains 6 and 15), suggesting that critical divergent events occurred in these 
domains. Furthermore, we observed co-localization of distinctive residues with missense 
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mutations in both the ABD and some Ig-like domains in rod 1. These suggested the 
importance of these regions in functional divergence of isoforms. 
 
1.3 Isolation of filamin function using mechanical techniques 
 Based on studies of the role of filamin in cellular stress pathways, we hypothesized that 
stress-induced conformational changes in filamin A Ig domains play a direct role in signaling 
by disrupting existing interactions or by introducing new ones. Therefore, it was important to 
investigate possible stress-induced conformational changes that could play functional roles. 
 
1.3.1 Single molecule unfolding 
Atomic force microscopy (AFM) has been commonly used to study the response of a 
protein to mechanical stress at the single molecule level. The most common AFM mode is 
called constant velocity (CV). In CV mode, domains are attached to a substrate. Next, a 
cantilever, which measures force, is attached to the protein. Then the molecule is pulled apart 
at constant velocity. Force builds up until the molecule quickly unfolds. The force at this 
point is considered the critical unfolding force (Fc). Filamin A has been studied using CV 
AFM and has an Fc in the range of 50-220 pN (16). AFM also has been used in constant-
force (CF) mode. CF pulling produces an end-to-end extension vs. time curve. The use of CF 
mode is a good technique to identify stable intermediate conformations of proteins pulled 
apart. As molecules are pulled apart they can stabilize into low energy conformations. A 
stable intermediate is observed when there is an extended period in which its end-to-end 
length stops increasing. 
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1.3.2 Molecular dynamics 
AFM does not produce an atomistic description of unfolding trajectories, so 
molecular dynamic simulations (MD) have been used to complement experiments. The use 
of MD to analyze the forced unfolding pathways of domains has traditionally been too 
computationally expensive to simulate length of time required to observe unfolding. 
Strategies implemented to avoid this limitation include using simplified protein models (119, 
120), or pulling with high forces or speeds. One major drawback of these strategies is that 
unfolding pathways can be altered under extreme conditions (121). 
Domain Unfolding force range Intermediate conformation 
TNI27 100-150 pN Loss of AB region contacts 
FN-III10 60-100 pN Loss of β strands A and B, 
β sheets slid past one another 
ddFilamin 4 50-60 pN Loss of B strands A and B 
Several AFM and MD studies of Ig or similar folds (Table 3) indicate that Ig domains 
can have force-induced metastable conformations. These include titin Ig-like domain 27 
(TNI27)(122-130), type III fibronectin domain 10 (FN-III10) (131, 132), and D. discoideum 
domain 4 (ddFilamin 4)(133-135). However, only fibronectin FN-III intermediates are 
reported to have functionality (132, 136). When cells are cultured on ECM they spread. 
Using their acromyosin contractile apparatus and their integrins, spreading cells pull on 
protein components of the ECM, including fibronectin. The forces generated on fibronectin 
can cause its domains to unfold partially to a stable intermediate, exposing cryptic integrin 
binding sites (136, 137), which mediate cellular adhesion. 
Table 3. Ig or similar domains with force-induced stable intermediates 
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1.3.3 Discrete Molecular Dynamics 
The Discrete Molecular Dynamic (DMD) simulation technique (138) is used to 
sample protein conformational space efficiently (138). DMD is a special variant of the 
molecular dynamics methods where continuous potential functions are simplified as stepwise 
functions, thus reducing DMD into collision-driven dynamics. Such an approximation 
enables DMD to sample protein conformations efficiently with at least three orders of 
magnitude increase in sampling efficiency over traditional molecular dynamics (138). Over 
the past years, our lab has developed a hierarchy of simplified protein models, from simple 
one-bead-per-residue to all-atom representations. Since simplified protein models are not as 
accurate as all-atom models, the two types of models can be coupled to increase the accuracy 
of molecular modeling without compromising computational efficiency. Multi-scale (MS) 
simulations can be achieved by iteratively performing simulations using high- and low-
resolution protein models. This idea represents the fundamental approach of multi-scale 
modeling; low-resolution models are used to sample the conformations of large-scale 
processes and systems, while higher-resolution models are used for improving accuracy. We 
have successfully applied MS-DMD methods to study dynamics of large molecules including 
vinculin (139), dynein (140), nucleosome (141, 142), and cystic fibrosis transmembrane 
conductance regulator (143, 144).  
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1.3.4 Results from mechanical techniques 
Physical stress on filamin: To study force-induced unfolding of filamin A using DMD we 
used all-atom models of Ig-like domains derived during the functional ET study. For each of 
the 24 Ig-like domains that make up filamin, we performed constant-force simulations by 
applying a set of physiologically relevant ranges of forces (0-315 pN) to the N- and C-
terminal Cα atoms of each domain. Based on these systematic DMD simulations, we 
estimated the critical force of unfolding of each individual domain and characterize the 
conformational changes under mechanical stress. We found that the critical forces are 
heterogeneous among the 24 domains due to the sequence differences. We also found that 
there is no significant difference between the critical unfolding forces of domains with and 
without N-terminal strands. We found that under small forces up to ~35 pN, which 
correspond to the physiological forces (145), most Ig-like domains remained in their native 
states. As the force increased up to the intermediate force levels of ~70 pN, large 
conformational changes take place. Interestingly, Ig-like domains featured a common initial 
conformational change, where the first β strand unfurls. Domains that lack their N-terminal β 
strands appeared similar to one another, maintaining their native-like conformation under low 
forces. At intermediate forces, they unfolded to a heterogeneous population of intermediate 
states similar to seven-stranded domains.  
Thermal stress on filamin: Additionally, the effect of temperature versus mechanical stress 
on unfolding pathways has been the subject of much debate (146). The general hypothesis is 
that thermally- and force-induced unfolding pathways are independent of each other since the 
thermal fluctuations are exerted on the protein globally, while the effect of mechanical force 
is localized and non-homogeneous. To examine whether the thermally- and force-induced 
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unfoldings are different, we also performed thermal unfolding of three Ig-like domains, 14, 
21, and 24. We found that thermally-induced unfolding shares the same initial unfolding 
intermediate state as forced unfolding, where the first strand unfolds. This observation 
suggested that filamin evolved to feature the intermediate state of unfolded N-terminal 
strand(s). Given the observation that the putative first strand of domain 20 interacts with 
domain 21 instead of forming a β sheet with the second strand, we proposed that an N-
terminal strand may act as a conformational switch that unfolds under stressed physiological 
conditions leading to exposure of cryptic binding sites, removal of native binding sites, or 
modulating the ternary structure of domains. 
 In Chapter 2 we used evolutionary trace method to create hypotheses about the 
functional importance of residues within the vertebrate filamin family. Our method improved 
upon the traditional methods by adding constraints that eliminate highly variable sites. These 
constraints limit hypothesis generation to only those sites in which at least one isoform is 
conserved throughout evolution. Our work suggested the possibility that filamin isoforms are 
regulated distinctly both in F-actin binding and in interacting with other proteins such as 
integrins. It also suggested the possibility of functional roles for N-terminal domains for 
which few binding partners have been identified to date. In Chapter 3 we analyzed the 
function of filamin as a mechanical protein using DMD simulation. We obtained mechanical 
properties of filamin A, including Ig-like domain critical unfolding forces, and unfolding 
pathways at biological levels of force. In addition, we analyzed how Ig domains react to 
thermal stress. Our results suggested the possibility that filamin acts as a conformational 
switch because at intermediate levels of force (35-70 pN), domains unfold to form a 
heterogeneous set of conformations, many lacking β strands A or B. 
  
 
 
 
 
Chapter 2 
Isoform divergence of the filamin family of proteins 
This chapter was submitted as a part of a manuscript to The Journal of Molecular Biology 
and Evolution; and is formatted in the journal style.  
 
2.1 Introduction 
Vertebrate filamin is a family of F-actin cross-linking proteins with members named 
A, B, and C (147). They have a dual role in cells as both mechanical proteins and scaffold 
proteins. As mechanical proteins, filamins participate in dynamic shaping and maintenance 
of the cytoskeleton, cross-linking F-actin into gels and fibrils. They also have a role in the 
physical stress-response and mechanoprotection of cells (58-60). Filamins also have a role in 
cellular cytoskeletal anchoring by binding the tails of transmembrane proteins such as 
GPIbα, integrins, channels, and receptors (45-47, 87, 88, 148). Filamin proteins also bind to 
cytosolic effector proteins and act as scaffold proteins for both inside-out and outside-in 
signaling, including F-actin remodeling. Filamin family members are greater than 64% 
similar and have both overlapping and distinct roles. We know much about filamin A, but 
less about filamin B, and C. Most knowledge has been gained by studying interacting 
partners and not through filamin centric research. Thus, the proteins studied have biased the 
knowledge we have about filamin. In this chapter we take a top-down approach to studying 
the function of filamin. We assume that family members diverged from a common ancestor 
and that subsequent gene duplication events created all three family members. The questions 
of interest are: which of the ancestral functional roles of filamin, after gene duplication, are 
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maintained across all isoforms, distributed between different isoforms, or are newly evolved 
within an isoform?  To answer these questions we use phylogenetic analysis, an evolutionary 
trace, and an all-atom structural model of filamin A. We analyze spatial and temporal 
patterns of filamin family divergence to give us insights into the structural elements involved 
in both isoform-distinctive and common function. The three components of this analysis are 
development of a structural model of filamin A; a phylogenetic analysis of invertebrate, 
invertebrate chordate, and vertebrate filamin paralogs; and an evolutionary trace analysis, all 
three of which we use to observe the divergences of individual filamin sites in a spatial and 
temporal context. 
  
2.2 Materials and methods 
We first use homology, modeling and superimposition, to create an all-atom model of 
filamin A. Then we use Bayesian phylogenetic methods to derive a phylogenetic tree of the 
vertebrate filamin family of proteins. We then analyze the site-specific divergence of filamin 
isoforms by performing a highly constrained evolutionary trace.  
 
Modeling 
An all-atom model of filamin A is created from homology models of individual 
filamin A domains. Most domains are joined by relative positioning pairs of domains onto a 
multi-domain structure of ddFilamin (PDB ID 1wlh) and then loops are generated to connect 
domains.  
Homology modeling is performed using the Modeler module of the InsightII from 
Accelrys Inc. (www.accelrys.com). Homology modeling uses a template structure from a 
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related protein to predict a structure for a target protein sequence. The homology models are 
evaluated for sequence-structure compatibility using the Verify-3D function of the Profiles-
3D module from InsightII. Verify-3D scores residues based upon how well they fit in their 
local environment. De novo loop generation is performed in SYBYL computational 
informatics software for molecular modeling from Tripos Inc. (www.tripos.com). To avoid 
residue clashes and approximate native structures, we relaxed pairs of linker-connected 
domains with DMD/Eris/Medusa (149-151). To create a filamin dimer we superimpose each 
self-association domain (24) onto a structure of a dimer of IgFLNc24 (PDB ID 1v05) using 
PyMOL.  
 
Actins-binding domain (ABD) 
The ABD of filamin is homology modeled using a template of ABD of α actinin in 
the closed conformation (PDB ID 1wku) (152). The protein threading server HHPRED (153) 
is used to identify suitable templates for the ABD of filamin A. The top hit is to the ABD of 
α actinin with an E value of 0. The architecture of filamin and the ABD of α actinin are 
similar except for a longer negatively charged linker between first and second CH domain of 
filamin (Figure 1 A, Appendix A).  
 
Ig-like domains 
Filamin A Ig-like domains are modeled using templates composed of homologous Ig-
like domains of human and Dictyostelium discoideum filamin (ddFilamin), except for the tri-
domain structure of domains 19-21 (PDB ID 2j3s). A multiple sequence alignment 
(MSA),used for template assignment, is derived from a structural alignment of the human 
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and ddFilamin Ig-like domains in Figure 1 B, Appendix A. A template for each target 
domain is chosen based upon its having both a sequence and an insertion pattern that are 
similar to the query. Table 1 in Appendix B contains the paired target/templates we use.  
 
Domain model validation 
Homology models of filamin domains generally have high sequence-structure 
compatibility scores (Table 2, Appendix B). Quality analysis of each domain is performed 
using Verify-3d module of InsightII (Accelrys Inc.). This analysis measures the compatibility 
of modeled residues with their structural environment. A quality score of greater than 0.1 
indicates a valid structural model with a correct fold (154), while a higher score indicates a 
more accurate model. Typical experimental structures score around 1.0. The mean Verify-3d 
score we obtain for Ig-like domain models is 0.89 with standard deviation 0.30. The score we 
obtain for the ABD is 0.75. The only model to produce a low score is IgFLNa18 (0.11). 
However, the homology model of IgFLNa18 has high sequence identity (64% id), and a low 
RMSD (0.23 Å) when compared to its IgFLNb18 template, suggesting that the IgFLNa18 
model is correctly built based on the template. Furthermore, the structure of the template 
itself has a low quality score of 0.56. Overall, the high mean quality score we obtain for the 
Ig-like domain models infers their high accuracy. Recently, the crystal structure of the 
filamin B ABD was released (PDB ID 3fer). This structure and our homology model have a 
1.1 Å RMSD, over 168 Cα atoms. The largest architectural difference between our model 
and this structure is the positioning of a highly ancestral set of residues that lead to the neck 
region (linker between CH 2 and IgFLN 1). This may have the effect of modifying the 
relative position of the ABD and IgFLN 1. 
  
  27 
 
Joining domains 
We oriented domains relative to one another using the multiple-domain structure of 
ddIgFLN 4-6. Ig-like domains with short linkers (mean linker length 3±1 (Table 2, Appendix 
B) have an extended conformation (Figure 2.2, domains 6-8) (62) and have been proposed to 
have the same relative conformation as ddIgFLN 4 and 5 (PDB ID 1wlh) (155). Popowicz et 
al. modeled extant ddFilamin using a similar technique (155). Domains surrounding hinge 
regions are first oriented similar to that of short linkers and then the distance between 
domains is extended to accommodate the larger linker. An adjustment to the orientation of 
domains around hinge 2, IgFLN 23 and IgFLN 24, is made based upon visual inspection of a 
structure of these two domains produced by small angle X-ray light scattering (156). After 
domain orientation, de novo loop generation is used to join domains.  
During homology modeling we identified several Ig-like domains that are potentially 
missing a β strand. As a result, we adjusted our method of modeling these domains. Ig-like 
domains are composed of two β sheets forming a β sandwich - one sheet with four (A-B-E-
D) β strands and one with three (G-F-C) β strands. Our analysis of IgFLNb18 (PDB ID 
2dmc) and IgFLNb20 (PDB ID 2e9i) revealed six-stranded Ig-like domains with most of β 
strand A forming a highly dynamic coil. In addition, the sequence of β strand A for these 
three domains shows low sequence identity with the canonical filamin β strand A sequence, a 
possible indication of a structural change. We, therefore, modeled Ig-like domains 18 and 20 
lacking β strand A. Structurally the loss of β strand A has the affect of placing the N- and C-
termini adjacent to one another thus inducing a compact multi-domain structure (Figure 2.2, 
Ig domains 17-19). Since IgFLN 18 lacked strand A we used ad hoc methods to determine its 
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relative positioning to domain 17. IgFLN 18 and 19 share a short linker so we used ddFLN 
superimposition to derive their relative positioning. We modeled IgFLN 19-21 using the 
structure of IgFLN 19-21 (PDB ID 2j3s) (93). Both tri-domain models (17-19, 19-21) have 
an elbow-like architecture that when incorporated in our structure produced a zigzag 
conformation. 
An analysis of IgFLNb16 (PDB ID 2ee9) also revealed a six-stranded Ig-like domain. 
However, sequence differences between filamin A and B, in β strand A, suggest potential 
isoform-specific conformational differences in Ig-like domain 16. The sequences of 
IgFLNa16, β strand A has several residues that are conserved to the canonical Ig-like domain 
(Figure 1 B, Appendix A), in contrast to IgFLNb16 and IgFLNc16. Therefore, we modeled 
IgFLNa16 with β strand A intact. Since the experimental structure of IgFLNb16, lacks β 
strand A, there is some ambiguity as to whether IgFLNa16 should have been modeled with or 
without β strand A.  
 
Phylogenetic analysis of the filamin family 
Data  
Filamin protein sequences (Table 3, Appendix B) are obtained from a search of 
genomic databases. The general procedure is to obtain protein sequences using tblastn with 
the query sequence of hsFilamin A on genomic databases. We only use sequences that have 
both the ABD and a large quantity of Ig-like domains (all but mosquito and sea urchin have 
the full complement of 24 Ig-like domains). The species included in this study are 
vertebrates: mammals (Homo sapiens, Mus musculus, Rattus norvegicus, Canis familiaris), 
Amphibians (Xenopus tropicalis), and teleosts (Danio rerio, Takifugu rubripes, Tetraodon 
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nigroviridis); urochordates: Ciona intestinalis, Ciona savignyi; and invertebrates: 
Strongylocentrotus purpuratus, Anopheles gambiae. Well-characterized sequences for Homo 
sapiens filamin are obtained from NCBI (http://www.ncbi.nlm.nih.gov/) (hsFilamin A 
(NP_001447.2), B (NP_001448.2), and C (NP_001449.3)). Vertebrate and urochordate 
sequences are obtained from the   Ensemble (release 41) database (http://www.ensemble.org) 
and invertebrates sequences are obtained from the NCBI database. Table 3 in Appendix B 
lists the sequences we use in the study. To obtain a full length Ciona filamin protein 
sequence with the full complement of 24 Ig-like domains we use the consensus sequence 
from the following predicted proteins (ENSCSAVP00000017581, 
ENSCSAVP00000017582, ENSCSAVP00000017578, ENSCSAVP00000017579, 
ENSCSAVP00000017577, ENSCSAVP00000017583, ENSCSAVP00000017585, 
ENSCSAVP00000017580, ENSCSAVP00000017584, ENSCINP00000006732).  
 
Tree construction 
Alignments are generated with the assistance of software alignment tools as well as 
by visual adjustment using both JalView (157) and Seaview (158). Mr. Bayes (159) is 
employed to calculate all phylogenetic trees and for ancestral reconstruction. The out-group 
chosen is a mosquito filamin from Anopheles gambiae (AGAP004335-PA). We use the rate 
matrix amino acid model equalin, and fixed rate model invgamma, 125000 generations, 
sample frequency of 100, and three independent runs. A burn-in of 250 is used to create 
consensus trees as indicated by convergence of test runs. All but one branch possesses a 
posterior probability of partition of 1.00. This single exception occurs within the mammalian 
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clade and possessed a posterior probability of (0.93). Tree generation software njplot is 
employed to render trees (160). 
 
 
 
 
 
 
 
Isoform-specific divergence 
Determining isoform-specific divergence consists of ancestral reconstruction 
followed by a site-specific evolutionary trace (ET) as detailed in Figure 2.1. Ancestors are 
reconstructed using Mr. Bayes at the clade branch points as indicated in this figure. We used 
an amino acid rate model equalin with a fixed rate model invgamma, and either 50000 or 
10000 generations, both of which converged well. To eliminate ancestral calls with high 
uncertainty a consensus of eighty percent of the generations have to agree on an ancestral 
residue. We indicated with an X any residue in the ancestral sequence that did not meet this 
criteria. Using an alignment of these ancestral sequences we performed an ET. At each site of 
 
Figure 2.1. Isoform-specific divergence. The analysis of isoform-specific divergence consists of 
ancestral reconstruction, aligning ancestral sequences, and an evolutionary trace of ancestral 
sequences. (A) Segment alignment of a section of the extant filamin protein sequences.  Lower 
alignment is of reconstructed ancestral sequences.  X is indeterminate residue. (B) Evolutionary 
trace results indicating sites are: “ancestral,” “distinctive,” or “other.” Ancestral implies the same 
biochemical type is maintained in each isoform.  “Distinctive” implies change to a new 
biochemical type in one isoform and then is fixed, while at least one other isoform is ancestral. 
“Other” implies a variable site. (C) The evolution of extant species are viewed as branching off the 
evolutionary tree that leads to humans.  Ancestors at the branch points are Teleostei (blue), 
Amphibian (green), and Mammalian (yellow).   
 
  
  31 
this alignment we monitor at periods Teleostei, Amphibian, or Mammalian, for a change in 
residue biochemical type that then becomes fixed until the human form. We additionally 
required that at least one isoform remained ancestral. Throughout this analysis we use a 
reduced amino acid type set consisting of 16 residue types: (S/T, I/L, K/R, D/E, F/Y), 10 
remaining single residues and a type for an insertion. We allow the skipping of at most one 
period to allow for period specific divergence. We also accout for divergence of Ciona by 
redefining the ancestral type, if all three Teleostei period ancestors are in agreement for 
residue type but disagreed with the common Ciona ancestor. The latter caveat occurred very 
infrequently. 
Information about polymorphisms leading to disease is derived from filamin A 
(P21333) and filamin B (075369) in the UniProt database (http://www.uniprot.org).  
 
2.3 Results 
All-atom model of filamin A  
We construct an all-atom structural model of a human filamin A monomer using 
homology modeling (see Materials and methods) (Figure 2.2). This monomer has an actin-
binding domain (ABD), 24 Ig-like domains, linkers and two hinge regions. In general, model 
construction consists of homology modeling individual domains, measurement of the quality 
of each model, positioning domains relative to one another, and generating linkers between 
domains. We then construct a filamin A dimer model by superimposing the 24th Ig-like 
domain of each monomer onto the X-ray structure of the dimer of IgFLNc24 (PDB ID 1v05).  
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Model Description 
The predicted structural model of filamin A is consistent with recent electron 
micrographs and experimental data (62) that suggest that filamin A has two distinct 
architectural regions, one consisting of domains 1-15 and having a linear extension of 
domains, and the other (domains 16-24) having a compact conformation. The linear region is 
similar to the linear conformation of filamin domains that are proposed to exist based upon 
the high-resolution structure of ddFilamin domains 4-6 (155). The compact region results 
from two domains, 18 and 20, lacking β strand A. Interestingly, early electron micrographs 
of filamin A (18, 161) have an overall dimension and appearance quite similar to our model.  
 
 
 
Figure 2.2. Atomic model of a filamin A dimer. Filamin A dimer and component domains are 
produced by homology modeling. In filamin we propose that there are two types of Ig-like domains, 
six-stranded because they are missing β strand A (e.g., domain 18) and seven-stranded (e.g., domain 
7). We propose that IgFLN 18 and 20 lack their first strand, which results in a conformation such that 
the N- and C-terminus of the domains coincide, causing a “zigzag” or kink conformation in distal C-
terminal domains. The entire dimer is displayed as a hybrid model, a space filling model (left 
monomer) and a cartoon (right monomer). The structural compaction caused by the kink region 
results in the length of eight C-terminal domains equal to 15.3 nm compared to the linear N-terminal 
domains of 30.2 nm. A 103° angle is observed between the filamin monomers and approximates the 
90° angle average observed in filamin electron micrographs. 
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Derivation of vertebrate filamin phylogeny  
To derive the phylogeny of vertebrate filamin we perform a Bayesian inference 
phylogenetic analysis on aligned filamin invertebrate, invertebrate chordate, and vertebrate 
sequences (Figure 2.3). All nodes of the consensus phylogenetic tree have at least a 90% 
level of confidence. Within the chordate filamin clade, we observe three monophyletic 
subclades, each corresponding to a different isoform of filamin. The single ascidian 
sequence, from the urochordate genus, cluster outside these three vertebrate subclades, while 
invertebrates are even more distantly related. Therefore, we hypothesize that two gene 
duplication events occur between the branching of urochordate and teleostei ancestors from 
the mammalian lineage during early vertebrate evolution to give rise to the three vertebrate 
filamins.  
Our phylogenetic study of vertebrate filamin suggests that the three isogenes of 
filamin (A, B, and C) originated from a single ancestral gene that existed prior to the advent 
of vertebrates and that it is also the progenitor to extant urochordate (tunicates) filamin. The 
tunicate Ciona intestinalis has been extensively studied as having a simplified body plan that 
mimics the ancestor to vertebrates (162). Tunicates have organs and systems in which filamin 
isoforms have been shown to play a developmentally critical role. These include, a well-
developed muscle of their one chambered heart (163), vasculature (163), and immune system 
that represents the prototype for the innate vertebrate immune system (164). Filamin binding 
partner and associated pathway orthologs have also been identified in ascidians, including 
specialized von Willebrand factor type A -like (165) and β1 integrin family –like members 
(1). The interaction between GPIbα (von Willebrand receptor) and filamin A is critical to 
platelet activation and adhesion as part of wound healing in vertebrates (2, 166). A recent 
report suggests that analogs of the von Willebrand factor and many other proteins involved in 
the vertebrate intrinsic wound healing pathway, do not appear to have a role in ascidian 
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wound healing (167), but play a role in ascidian clot formation during allo-rejection response 
(167). Thus, it is possible that ascidian filamin have similar protein-protein interactions, but 
may function in pathways that do not necessarily lead to the same overall biological function. 
Spatial and temporal divergence  
The single urochordate Ciona filamin ancestor, as the progenitor to the three 
vertebrate isoforms, gives us a snapshot of parental function and allows us to track, through 
sequence analyses, the maintenance of parental function and the evolution of neo-
functionality in the three isoforms. Bayesian ancestral reconstruction is used to derive the 
ancestral sequences required for this analysis. Investigating an evolutionary trace for each 
 
 
Figure 2.3. Phylogenetic analysis of the vertebrate filamin family of proteins. Phylogenetic Bayesian 
analysis of aligned invertebrate and chordate filamin protein sequences suggests that urochordate Ciona 
filamin is closely related to the chordate common ancestor of the three vertebrate filamin isoforms. Gene 
duplication took place during early vertebrate evolution resulting in three filamin isoforms in Teleostei. 
The level of confidence in all branches is high. An asterisk (*) denotes branch points in which we derived 
ancestral sequences for subsequent isoform-specific divergence analysis. (Abbreviations: Ciona family: 
Ciona Intestinalis and Ciona Savignyi) 
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site in the multiple sequence alignment of reconstructed ancestors is then used to identify 
three characteristics. (1) The location and type (see Materials and methods) of an accepted 
mutation. (2) The isoform that an accepted mutation occurs in. (3) The ancestor in which the 
substitution first occurs. If at a particular site, a reside type is conserved across all isoforms 
including the Ciona ancestor, then maintenance of parental functionality in all isoforms is 
hypothesized to have occurred. We call these residues “ancestral.” If, however, at this site at 
least one isoform has maintained the residue type of the ancestral Ciona, and at least one of 
the other isoforms became fixed to a new residue type, this suggests that during evolution 
both maintenance of ancestral functionality within one isoform and derivation of neo-
functionality within another isoform occurs. We call these isoform-specific divergent 
residues “distinctive.” All other residues are called “other.” We further annotate the class-
distinctive residues by the period in which the divergence occurs as Teleostei, Amphibian, or 
Mammalian, thus a temporal categorization of divergence. Our method of isoform-specific 
divergence analysis is more restrictive than other analyses such as the “Evolutionary Trace” 
method developed by Lichtarge et al. (168), since we require maintenance of ancestral 
functionality in at least one isoform. 
 
Isoform conservation and class-distinctive divergence 
We quantify both conserved and class-distinctive residues in the context of the whole 
protein. We find that filamin isoforms are 64% similar to one another and the common 
ancestor, and 21% of the sites are class-distinctive (Figure 2.4 A). Of these class-distinctive 
sites, 78% diverge in the Teleostei period. Class-distinctive changes have few additions in 
the Amphibian period and a modest increment in the Mammalian period. The percentage of 
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class-distinctive sites by isoform is: filamin A 35%, filamin B 43%, and filamin C 22% 
(Figure 2.4 B). Thus, we hypothesize that filamin B contains the most neo-functionality and 
filamin C contains the most parental functionality.  
Isoform conservation across domains 
Quantification of the number of ancestral residues within domains identifies domains 
that played critical roles in maintenance of parental functionality. We find that conserved 
residues are not equally distributed implying potential conservation of interfaces in domains 
also outside the most extensively studied domains 16-24. This is observed from a bimodal 
distribution (Figure 2, Appendix A) of conservation with the first mode ~55% conserved, and 
the second mode about ~70% conserved. Between domains 2-15, domains with lower 
conservation are interspersed with domains of higher conservation. Most domains known to 
participate in protein-protein interactions (16-24) are contained within mode 2. Surprisingly, 
a number of domains that currently have little evidence of associated function also have as 
large a proportion of ancestral residues, suggesting maintenance of ancestral functionality 
beyond just fold maintenance (e.g., Ig-like domains 3, 4, 9, 12 and 14). It should be noted 
that non-conserved residues could either be “class-distinctive” or “other.” 
Isoform class-distinctive divergence across domains  
Our evolutionary trace analysis reveals ancestral conservation and isoform class-
distinctive divergence down to the spatial granularity of an individual residue and temporal 
granularity to three periods – Teleostei, Amphibian, and Mammalian. To identify domains 
that may play a critical role in isoform divergence and the adoption of neo-functionality we 
quantify their class-distinctive residues (Figure 2.4 C). Since only 22% of the class-
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distinctive residues occurred after the Teleostei period, we limit this analysis of divergence to 
only within the Teleostei period.  
The ABD is highly conserved, thus all isoforms share similar ancestral function. Two 
domains highlighted by this analysis are CH 1 and CH 2 of the ABD. CH 2 with several 
class-distinctive residues (7, 6, and 1 for A, B, and C, respectively) shows greater isoform 
differentiation than CH 1 (1, 1, 2 for A, B, and C, respectively). These data indicate that CH 
1 is nearly ancestral and has few class-distinctive residues in each isoform, yet CH 2 has a 
varying divergence pattern with A and B diverging from the common ancestor and C 
remaining the closest to the parental form. ABD CH 2 has been proposed to play a regulatory 
role (169), hence it is possible that isoforms differ in their regulation of actin-binding.  
Although most protein interactions have been isolated to domains 16 and above, we 
do not see a clear delineation in divergence pattern between this and the preceding region. 
This pattern suggests potential limitations in experimental procedure, caused by the extensive 
use of the yeast two-hybrid method to identify interacting partners with filamin. All isoforms 
have diverged in almost every Ig-like domain, thus divergence through class-distinctive 
residues occurred ubiquitously, but with variations in degree, rather than through modes such 
as localization to a limited number of specific domains. There are however, isoform distinct 
patterns of divergence and some individual domains are notable for extreme values of class-
distinctive residues, a possible indication of isoform-specific functionality. We identify two 
global patterns. First, in almost every domain filamin A and B have more class-distinctive 
residues than filamin C. Second, there appears to be two regions of class-distinctive residues 
over domains. N-terminal domains fluctuate between low and high distinctive-residues 
counts.  C-terminal domains in rod 2 have lower numbers of distinctive residues. 
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Figure 2.4. Quantifying the divergence of filamin isoforms. (A) Similarities between isoforms and 
common ancestor. ABC – All three; AB, BC, AC – Two are similar, one distinctive.  A, B, C – One similar 
and one is distinctive; Other – All other sites. Filamin isoforms retained 64% similar residues during 
evolution. Overall filamin C retained the most similar residues with the common ancestor. (B) The number 
of distinctive residues in each isoform and period (Mammalian, Amphibian, Teleostei), reported as percent 
of the total number of isoform residues.  Most divergence is in Teleostei.  Filamin A and B diverge about 
equally, while C diverge the least. (C) Distribution across filamin domains of Teleostei period distinctive 
residues.  Right graph is the histogram of distributions on left.  The composition of many individual 
domains reflects the overall composition (Mean and standard deviation per domain: A 7±3, B 9±5, C 4±2).  
Domains near the C-terminus have a lower number than proceeding domains (20 and above A, 19 and above 
B, 16 and above C).  Large counts within isoform: A, 17 and18; B: 6 and 15; C: 11 and 16.   Low (1 or 0) 
counts within isoforms: A, CH 1, 14, 21; B: CH 1 and 20; C: CH 2 and 6, 9, 17, 19, 21, and 23.  
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These regions differ in location for each isoform (filamin A: 1-20, 21-23; filamin B: 1-19, 
20-23; filamin C: 1-16, 17-23). Even within these broad regions there are individual domains 
with extreme counts of class-distinctive residues. In Filamin A, Ig domains 14 and 21 have 
very few class-distinctive modifications, and domains 17 and 18, have many class-distinctive 
residues. In filamin B, domain 20 has hardly diverged, while domains 6 and 15 has extreme 
counts of class-distinctive residues. In fact, domains 6 and 15, have more class-distinctive 
residues than any other domain, therefore they may have played a prominent role in 
developing filamin B neo-functionality. In filamin C, domains 9, 17, and 21 have no class-
distinctive residues; whereas, domains 11 and 16, have a relatively large number of class-
distinctive residues. Domains 11 and 16 also have a large number of class-distinctive 
residues in filamin A and B. Thus, in each isoform domains some domains maintain parental 
function while others have developed neo-functionality. 
 
A structural view of conservation and divergence 
To increase our understanding of the pattern of divergences, we place the “ancestral,” 
“distinctive,” and “other” residues in the spatial context of our model of filamin A. We also 
place class-distinctive residues in a temporal context as either from the “Teleostei,” 
“Amphibian,” or “Mammalian” period. In addition, to gain further insights into degree of 
class-distinctive change as well as biological significance, we observe class-distinctive 
residue relative positioning (such as surface exposed and clustering) while noting the status 
of surrounding residues, e.g. are class-distinctive residues observed in an ancestral or 
variable background?  Do they co-localize with mutations that lead to disease?  A single 
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accepted mutation in an ancestral background can indicate a minor modification to ancestral 
function, whereas a cluster of accepted mutations can indicate neo-functionality. 
We report our findings for well-characterized domains that have known binding 
partners in filamin A, IgFLN 21-β7integrin (PDB ID 2BRQ) (5) (Figures 2.5 A and 2.6 A), 
IgFLN 17-GPIbα (PDB ID 2BP3) (2) (Figures 2.5 B and 2.6 B), and ABD (2) (Figures 2.5 C 
and 2.7 C). In addition, we examine the spatial distribution of class-distinctive residues for 
domains in the range 5-10 and 14-18 (Figures 2.8 and 2.9). 
 
Adhesion protein binding domains 
 During the Mammalian period filamin isoforms distinctively diverge in domain 21 
at a site that is relevant to binding the developmentally critical binding partners, integrins. 
We find one class-distinctive substitution (Figure 2.5 A) along β strand C in the well-
characterized ligand-binding interface, an ancestral Ser/Thr in filamin B and C changed to an 
Ala at residue 2272 in filamin A during the Mammalian period. This class-distinctive site is 
localized to the end of the ligand-binding pocket. This site is suggested to be critical for 
binding based on in-vitro mutational studies (5) and several NMR perturbation (5, 49, 93) 
studies. Kiema et al. showed that A2272 A2274/DK (a phosphomimic) diminished binding, 
while the substitutions AA/ST (ancestral residue type) did not (5). This result suggests the 
possibility of isoform distinct regulation of binding integrins, although there is no evidence 
for this to date. 
Domain 17 has two Teleostei period distinct sites in the binding pocket with GPIbα 
(Figure 2.5 B). On the N-terminal end of the interface, an ancestral Ser (filamin A S1899) to 
class-distinctive Asp substitution is observed in filamin B. On the C-terminal end, an 
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ancestral filamin C Val to class-distinctive Ile substitution is observed in filamin A and B. 
The N-terminal class-distinctive site aligns with the class-distinctive site in the integrin-
binding interface. Evidence for its critical nature comes from the site-directed-mutagenesis of 
the adjacent ligand residue (170). The Ser to Asp class-distinctive substitution at this site 
suggests the possibility of isoform distinct regulation of interactions involving this domain, 
although there is no evidence for this to date. Class-distinctive sites on domain 17 and 21 
also localize outside the well-characterized binding interface (Figures 2.6 A and B), 
suggesting the possibility of other modes of binding.  
Based upon the class-distinctive residue profile of Ig domain 21, we also identify 
other domains that have a class-distinctive residue at the N-terminus of β strand C (Figure 
2.6 C), similar to that of domain 17 and 21. We find that IgFLNc14, IgFLNa19 and 
IgFLNb19 have the closest match. Of these three domains, IgFLN 19 is most similar to 
IgFLNa21. In addition, the substitutions of serine/threonine residues in class-distinctive sites 
appeared to be a recurrent pattern. There is some evidence that ligands bind multiple 
domains, including domain 19 (2, 5). Therefore, it is possible that isoforms distinctively 
diverge at analogous sites within different domains because these locations are good targets 
to modulate binding of the same ligand.  
 
Actin-binding domain 
The N-terminal ABD is composed of two CH domains. These domains are connected to the 
Ig-like domains with a larger linker. The first CH domain is more conserved than the second 
and is involved in both directly binding F-actin and regulation of F-actin binding, by 
interacting with calcium-activated calmodulin. The second domain is suggested to have a 
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regulatory role in binding F-actin (15). Quantification of class-distinctive residues suggests 
that isoforms have distinctively diverged to a much greater extent in CH 2 than CH 1. Within 
CH 2, class-distinctive sites are localized to a large surface on helices B, C, E and F (Figure 
2.5 C and Figure 2.7 C). The biochemical nature of class-distinctive residues differed by 
isoform. Class-distinctive changes in filamin A are primarily to serine residues. Most filamin 
B class-distinctive residues are on helices (except Y155). The only filamin C class-distinctive 
residue that localizes to this region is a large polar residue that diverged from a charged 
residue. Transitioning from a more biochemically charged surface to a more uncharged polar 
surface appears to be the general trend. We also observed mutations in this region that co-
localize with class-distinctive residues. Mutations that localize to this region have been 
reported as “gain-of-function” mutations leading to similar developmental skeletal disorders 
in both filamin A and B (107). Thus, we have isolated a particular region of CH 2 where all 
isoforms have distinctly diverged. Furthermore, we show that class-distinctive residues co-
localize with mutations causing disease in both filamin A and B. Therefore, we propose 
class-distinctive residues within this region are important for isoform divergence, and these 
changes can be involved in pathways that when mutated lead to disease. One possibility is 
that isoforms distinctly regulate actin-binding, especially since filamin A contains a large 
number of distinctive serine residues. 
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Figure 2.5. Analysis of class-distinctive residues in domains with well-
characterized interfaces.  Each column contains an all-atom model of filamin A, 
differentially colored based upon isoform class-distinctive divergence (sand = 
ancestral, class-distinctive (blue = Teleostei, green = Amphibian, yellow = 
Mammalian), white = other).   Ligands are colored in light cyan with residues adjacent 
to class-distinctive residues in dark cyan.  Ligands are space-filled for experimental 
and dotted for hypothetical complexes.  The N-terminus of the ligand is colored 
magenta. (A) IgFLN 21 in complex with β7 integrin.  There is one class-distinctive 
residue in the interface on filamin A. (B) IgFLN 17 in complex with GPIbα.  There is 
one class-distinctive residue on filamin A and two on filamin B at the interface. (C) 
Surface model of the filamin A actin-binding domain (ABD), consisting of two 
calponin homology (CH) domains.  CH 1 is highly ancestral, while CH 2 has a few 
class-distinctive residues that cluster around a few subdomains.  Filamin A and B have 
more class-distinctive residues than C, and those co-localize near mutations that cause 
disease (pink).   
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Figure 2.6.   Distinctive 
divergence outside the binding interface of Ig-like domains 17 and 21. Coloring as in Figure 2.4. (A) 
IgFLN 21 in complex with β7 integrin (PDB ID 2BRQ).  Top row has the same orientation as Figure 2.4.  
Row 2, 180° rotation, views the CD face of the domain.  β strand D is opposite ligand.  All isoforms 
have class-distinctive residues (yellow) surrounded by highly ancestral regions outside the binding 
pocket.  (B) IgFLN 17 in complex with GPIbα ligand residues (PDB ID 2BP3).    Similarly, domain 17 
has distinctive residues outside the binding pocket surrounded by ancestral residues (Filamin A and B 
only) (C) Domains 14 and 19 have a profile of distinctive residues along β strand C that is similar to 
both IgFLN 17 and IgFLN 21.  
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Figure 2.7. Spatial and temporal distribution of divergence in the actin-binding domain. 
Coloring is the same as in Figure 2.4.  In addition (top row) violet is ancestral and similar among 
isoforms; bottom row (pink) shows mutations leading to disease. (A) Surface representation of the 
actin-binding domain (ABD) and filamin Ig domains 1-5.  Surface is highly ancestral. (B) 180° 
rotation of A about the vertical axis.  Domains 1 and 2 have an asymmetric conservation pattern. (C) 
The ABD subdomains, calponin homology (CH) domains 1 and 2.  CH domains contain seven 
helices labeled A-G on filamin C. Top is cartoon, bottom is space-filled model.  Most of the 
distinctive residues in the ABD are localized to one region of CH 2, composed of helices B, C, E and 
F. Class-distinctive residues also co-localize with disease-causing mutations.  Filamin A class-
distinctive substitutions are mostly serine residues, while filamin B favors large bulky residues.  
Filamin C has fewer class-distinctive residues and is more ancestral than filamin A and B. 
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Figure 2.8.  Distinctive divergence of Ig-like filamin domains 5-10. Coloring same as 
Figure 2.4. (A) Space-filling model of Ig-like domains 5-10 of filamins A, B, and C. Some 
domains are highly conserved (e.g., IgFLN 7), and some are highly divergent in each isoform 
(e.g., IgFLN 6).   Arrows in IgFLN 6 point to clustering of distinctive residues, including to an 
entire surface on IgFLNb6.  Filamin C is more ancestral but nearly as variable.  Unitary 
mammalian distinctive residues appear on most domains. (B) This side of the domains appears 
to have more distinctive residues than the other side, especially in filamin B.  Disease 
mutations are surface-exposed but closer to the ends of the domain. 
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Other domains 
Results from the quantitative analysis of filamin class-distinctive residues, implies 
that filamin isoforms diversified in central domains. Here we examine class-distinctive 
residues mapped onto Ig-like domains 5-10 (Figure 2.8) and 14-18 (Figure 2.9).  
Most class-distinctive residues in IgFLN 5-10 (Figure 2.8) are surface exposed and in 
loops between β strands of each domain. The sites surrounding class-distinctive residues on 
 
 
Figure 2.9. Distinctive divergence of Ig-like filamin domains 14-18. Coloring same as Figure 2.4. 
(A)Space-filling model of Ig-like domains 14-18 of filamin A, B, and C.  The hinge between 15 and 16 is 
highly variable.  Filamin C is highly conserved in each domain and has isolated Mammalian period 
distinctive residues.  Filamin B is most divergent, especially domain 15 (arrow). The loop between β-strand 
A and B on IgFLN 15 contains a distinctive deletion in filamin B of 8 amino acids.   Filamin A and C are 
similarly conserved.  Filamin A and B have clusters of distinctive residues in domain 17.  Domain 18 
appears to diverge equally in the same region of each isoform.  This region includes the unique feature of 
this domain, lacking an intact β strand A. (B)180° rotation around the vertical axis of A.  Domains are 
similar as described in A.  
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most domains are also highly ancestral. Filamin C diverged during the Mammalian period, 
whereas filamin A and B started diverging in the Teleostei period and continued into the 
Amphibian period. IgFLNb6 is noted for large numbers of class-distinctive residues that 
cluster to various regions of the domain (arrows in Figure 2.8 A point to class-distinctive 
residue clusters: filamin A. surrounding β strand G (3 arrows); filamin B, loop CD (one 
arrow); filamin C, on β strand G (one arrow)). The largest cluster maps to a surface exposed 
loop between β strands C and D. This multi-residue substitution encompassed a negatively 
charged loop (784DARVLSEDEEDV795) in filamin B replacing an ancestral hydrophobic loop 
(APGVVGPAEADI) of filamin A and C. A motif scan (http://www.elm.eu.org/) suggests 
that filamin B potentially contains either a 14-3-3 or a casein kinase II (CK2) 
phosphorylation site and filamin A and C potentially contains an SH3 binding motif. Another 
domain with an interesting pattern of class-distinctive residues is IgFLN 9. The age of the 
class-distinctive residues in IgFLN 9 illustrates that this domain diverged both early in 
vertebrate and later during mammal evolution. One particular region (Figure 2.8 B IgFLNa9 
and IgFLNb9, near center of the domain) contained two class-distinctive sites that became 
fixed in filamin A during the Teleostei (Q1115L, along β strand D) and Mammalian (P1087R, 
along β strand B) period and in filamin B during the Teleostei period (P1087E, Q1115S). In 
each case, although both isoforms utilized the same site, divergence is to a different residue 
type. Close to these residues is a cluster of class-distinctive residues on filamin A that striped 
across β sheet ABED. These residues are mostly from the Mammalian period and identified a 
rare cluster of mammalian divergence in filamin A. In a previous section we noted that 
IgFLNc9 is absent of Teleostei period class-distinctive residues. IgFLNc9 however, 
contained several Mammalian period class-distinctive residues, thus all three isoforms 
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diverged in the Mammalian period. It is also worth noting that domain 10 has a cluster 
residues associated with disease in close proximity to class-distinctive residues just described 
(Figure 2.8 A). Thus, in general domains in the range 5-10 are highly conserved, however we 
find many class-distinctive sites in which filamin A and B co-localize and filamin C is 
ancestral (e.g. IgFLNa8 and IgFLNb8 and IgFLNa9 and IgFLNb9). This pattern suggests that 
filamin A and B are diverging from ancestral function that filamin C possesses.  
Ig-like domains in the range 14-18 are noted for their large quantities of class-
distinctive residues relative to other domains. Class-distinctive divergence in this region 
occurs mostly in loop regions towards the terminal ends of each domain (Figure 2.9). 
Divergent residues are also in highly ancestral environments. There is a broader spatial 
distribution of class-distinctive residues in domains in the range 14-18 than domains in the 
range 5-10. An extreme example of this is class-distinctive residues in domains IgFLNb15, 
b16 and b17 compared to IgFLNb7 and b9. In domain IgFLNb15 class-distinctive residues 
clustered in 2-3 large groups, each surrounded by ancestral residues. One of these clusters 
localizes to eight residues in the turn between β strand A and B that is encoded by a single 
exon (171). This region has been previously categorized as an alternative splice variation in 
filamin A (172) and a deletion in FLNb (171). These previous classifications are consistent 
with our findings that filamin B distinctively diverged from ancestral filamin A and C by a 
deletion in this region. A motif scan suggests that this region may contain a GSK-3 
phosphorylation site. As noted earlier, IgFLNa18 has a large number of class-distinctive 
residues. There is a similar number of class-distinctive residues in both filamin A and B, and 
almost every class-distinctive site co-localizes between isoforms. This highly class-
distinctive region overlapped with β strands A, B and G. When we derived a homology 
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model for a filamin monomer, we modeled a turn in the linear extension of domains due to 
our observation that β strand A in this region lacked residues bound to β strand B. Since 
isoform divergence localize with this unique feature, each isoform may have a distinct intra-
domain architecture between domains 17, 18, and 19. The other domain we modeled lacking 
β strand A (21) is highly ancestral in the analogous region (not shown) suggesting that the 
architecture of 19, 20, and 21 is preserved from the common ancestor in each isoform. 
 
 
 
 
 
Figure 2.10. Distinctive residues associated with mutations 
causing disease. Coloring same as Figure 2.4. (A) IgFLNa9 
and IgFLNa10 are surface models showing localization of 
distinctive and ancestral residues and residues with disease-
causing mutations. (B) IgFLNb14 also shows similar 
localization. 
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Finally, we note that some class-distinctive residues co-localize with the sites of 
mutations causing disease (Figures 2.8, 2.9, and 2.10 A and B). While direct co-localization 
on a particular isoform is observed (e.g. IgFLNa10 and IgFLNb15 Figure 2.10 A and B), we 
also observed inter-domain localization (Figure 2.8 B, intersection between IgFLNb7 and 
IgFLNb8) and localization to homologous sites between domains (e.g. IgFLNa10 and 
IgFLNb10). Sites where mutations exist are predominantly surface exposed on loops between 
β strands, or near linkers between domains. Furthermore, almost all these mutations are on 
residues labeled ancestral. These data suggest that there is a correlation with class-distinctive 
changes and etiology of disease. One possibility is that disease mutations interfere with 
protein-protein interactions, another possibility is that disease mutations interfere with 
structural aspects of domains.  
 
2.4 Discussion 
Using phylogenetic analysis, an evolutionary trace, and an all-atom structural model 
of filamin A, we analyze spatial and temporal patterns of filamin family divergence to give 
us insights into structural elements involved in isoform class-distinctive and common 
function. The three components to this analysis consist of development of a structural model 
of filamin A; a phylogenetic analysis of invertebrate, invertebrate chordate, and vertebrate 
filamin paralogs; and an evolutionary trace analysis, which we use to observe the divergences 
of individual filamin residues in a spatial and temporal context. 
The predicted structural model of filamin A is consistent with recent electron 
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micrographs and experimental data (62) that suggests that filamin A has two distinct 
architectural regions, a region consisting of domains 1-15 having a linear extension of 
domains, followed by a region (domains 15-24) having a compact conformation. The linear 
region is similar to the linear conformation of filamin domains that are proposed to exist 
based upon the high-resolution structure of ddfilamin domains 4-6 (155). The compact region 
results from two domains, 18 and 20 lacking β strand A. Interestingly, early electron 
micrographs of filamin A (18, 161) have an overall dimension and appearance quite similar 
to our model.  
 Our phylogenetic study of vertebrate filamin suggests that the three isogenes of filamin 
(A, B, and C) originated from a single ancestral gene that existed prior to the advent of 
vertebrates and that it is also the progenitor to extant urochordate (tunicates) filamin. The 
tunicate Ciona intestinalis has been extensively studied as having a simplified body plan that 
mimics the ancestor to vertebrates (162). Tunicates have organs and systems in which filamin 
isoforms have been shown to play a developmentally critical role. These include a well-
developed muscle of their one chambered heart (163); vasculature (163); and immune 
system, that represents the prototype for the innate vertebrate immune system (164). Filamin 
binding partner and associated pathway orthologs have also been identified in ascidians, 
including specialized von Willebrand factor type A -like (165) and β1 integrin family –like 
members (1). The interaction between GPIbα (von Willebrand receptor) and filamin A is 
critical to platelet activation and adhesion as part of wound healing in vertebrates (2, 166). A 
recent report suggests that analogs of the von Willebrand factor and many other proteins 
involved in the vertebrate intrinsic wound healing pathway, do not appear to have a role in 
ascidian wound healing (167), but play a role in ascidian clot formation during allo-rejection 
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response (167). Thus, it is possible that ascidian filamin have similar protein-protein 
interactions, but may function in pathways that do not necessarily lead to the same overall 
biological function.  
Evidence for the significance of our results includes observations of class-distinctive 
residues that co-localize with disease mutations, localize to critical sites within ligand 
binding pockets, or have the potential to be involved in F-actin binding regulation. Other 
evidence for the significance of our results comes from the placement of class-distinctive 
sites within regions of the ABD that are functional in homologous ABDs. For example, we 
find that a region in ABD CH 2 of α-actinin, reported to be associated with phospholipid 
binding (173) contains a high concentration of class-distinctive sites in filamin. This 
observation is consistent with the report that filamin function is also regulated by 
phopholipids in vitro (174) and we hypothesize some of our sites contribute to sensitivity to 
lipid regulation.    
Our evolutionary trace analysis reveals ancestral conservation and isoform class-
distinctive divergence down to the spatial granularity of an individual residue and temporal 
granularity to three periods – Teleostei, Amphibian, and Mammalian. We observe a non-
uniform distribution of class-distinctive residues that varies over periods, and across domains 
and isoforms. Most protein interactions have been isolated to domains 15 and above. 
However, we do not see a clear delineation in divergence pattern between this and the 
preceding region, suggesting potential limitations in reported interactions resulting from the 
method used to initially identify interactions with filamin, the yeast two-hybrid method. Our 
methods, however, are unbiased in this way, treating each domain independently and of equal 
significance. We also find that conserved residues are not uniformly distributed (Figure 2, 
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Appendix A), implying potential conservation of interfaces in domains also outside the most 
extensively studied domains 15-24. Additionally, the temporal distribution of class-
distinctive sites is not uniformly distributed. For example, we find it intriguing that some 
domains have Mammalian class-distinctive residues that clustered both in time and space 
(e.g. domain 9 with many Mammalian class-distinctive residues). Since filamin is involved in 
many biological processes critical for mammalian development (heart involvement for 
instance) we feel that these few clusters can hold the keys to important changes in 
mammalian evolution, and thus should be the object of future investigations. 
We also hypothesize that the class-distinctive sites we identify may contribute to the 
evolution of isoform class-distinctive behavior in several ways, including variable specificity 
in binding; differential regulation of binding of adhesion proteins, effector proteins, and F-
actin; and potentially class-distinctive modulation of inter-domain structure. For example, 
over 35% of class-distinctive residue changes in filamin A and C involve changes to or from 
S/T residues while only 11% of class-distinctive changes in B involve S/T residues. Thus, 
filamin isoforms are likely to have different roles in signaling as phosphoproteins. As an 
example of identifying isoform variable specificity in binding, we identify a class-distinctive 
residue on each of filamin B and filamin C, that subsequently was identified as critical for 
distinct binding of filamin A to FILGAP (175).  
Since filamin plays a critical role as a structural protein (18) we also hypothesize that 
some of the class-distinctive residues we observe may mediate the structural characteristics 
of isoforms filamin, which may translate into distinct structural roles of isoforms in cells. 
Recently, Kesner et al. showed that filamin Ig domains have a heterogeneous set of stable 
conformations when forced to unfold under biologically significant levels of force (176). The 
simplest explanation for the heterogeneity of unfolding is primary sequence differences 
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between Ig domains. Since isoforms also differ in primary sequence, their Ig-like domains 
could have different forced unfolding properties. These properties include the stress required 
to change conformation and the stable intermediate conformation induced by force. It is 
possible that class-distinctive residues mediate response to stress. In support of this 
hypothesis, we find many filamin A class-distinctive residues in domain 18 that localize to 
the region we associate with having an aberrant first strand, suggesting that these distinctive 
residues play a role in the six-stranded conformation. In addition, filamin A has been 
reported to play a critical role in both exogenous and intracellular stress sensing (57, 58, 
177). Therefore, isoform-distinct stress sensing could potentially play a role in how different 
cells respond to stress. 
  
 
 
 
 
Chapter 3 
N-terminal strands of filamin Ig domains act as a conformational switch under 
biological forces 
 
This chapter was published as a part of a manuscript to Protein: structure, function, and 
bioinformatics structure, Function, and Bioinformatics; and is formatted in the journal style. 
 
3.1 Introduction  
Filamin family members (A, B, and C) are composed of an actin-binding domain and 
subsequent 24 immunoglobulin(Ig)-like domains. Filamins have been shown to play an 
important role in maintaining the rheological properties of the actin cytoskeleton (17). 
Filamin molecules can cross-link F-actin fibrils into actin-networks. As mechanical proteins, 
filamins localize to the cortex, stress fibers, and muscle Z-line. Besides their critical roles as 
mechanical proteins, filamins are also involved in cellular response to stress. Filamin A has 
been postulated to respond to cues from the stress environment of cells, as reported from its 
involvement in cell-fate determination (56), activation of platelets (44, 45, 178), and 
mechanoprotection (58, 61). How could filamin A transduce the stress state of a cell?  Some 
studies report that filamin A turnover and ability to bind F-actin can be regulated through its 
interactions with calmodulin and calpain, proteins that are activated by changes in cellular 
calcium level (15, 56, 179). Calcium levels in turn fluctuate with cellular stress levels (99). 
Other studies suggest that filamin A’s role as a scaffold protein, binding over 70 proteins 
(69), is modulated by its quaternary structure, which in turn could be regulated by either 
physical or thermal stress (93, 180). Based on these studies, we hypothesize that stress-
induced conformational changes of filamin A play a direct role in signaling either by 
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disrupting existing interactions or by introducing new interactions. Therefore, it is important 
to investigate possible stress-induced conformational changes that could play a functional 
role. 
To study force-induced unfolding of filamin A using DMD we need an atomistic 
structure of filamin A. However, structures of only five of the 24 Ig-like domains of filamin 
A have been experimentally determined (2, 5, 93, 181). Hence, in this study we use the all-
atom structure of filamin A derived from comparative modeling in an earlier study (Kesner et 
al. submitted). The average sequence similarity of all the Ig-like domains is > 40%. 
Therefore, we expect the homology-derived structures to be close to their native structures 
(182). In that study we observed that there are two classes of Ig-like domains in filamin: six-
stranded (lacking the N-terminal strand) and canonical seven-stranded. Domains 16, 18, and 
20 are six stranded. In a recent crystal structure of domains 19-21 it was observed that the 
putative first strand of domain 20 interacts with domain 21 instead of forming a β sheet with 
the second strand. This interaction has been proposed to inhibit domain 21’s interaction with 
other binding partners (93). Based on this quaternary structure it is possible that β strand A of 
an Ig-like domain could form complementary strands with adjacent Ig-like domains. Hence, 
we hypothesize that unraveling of the N-terminal strand of Ig-like domains could initiate 
inter-domain interactions through that strand. We study the six-stranded Ig-like domains 
from two perspectives. First, we compare domains 16 and 18 to that of domain 20 (whose 
structure has been determined) (93) to study if the six-stranded domains have similar 
physical characteristics. Second, we compare these domains to the seven-stranded domains to 
understand the role of the missing strand. 
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For each of the 24 Ig-like domains that make up filamin, we perform constant-force 
simulations by applying a set of physiologically relevant ranges of forces (0-315 pN) (16). 
Based on these systematic DMD simulations, we estimate the critical force of unfolding of 
each individual domain and characterized the conformational changes under mechanical 
stress. We find that the critical forces are heterogeneous among the 24 domains due to the 
sequence differences. We also find that there is no significant difference between the critical 
unfolding forces of domains with and without N-terminal strands. We find that under small 
forces up to ~35 pN, which correspond to the physiological forces (145), most Ig-like 
domains remain in the native states. As the force increases up to the intermediate force levels 
of ~70 pN, large conformational changes takes place. Interestingly, Ig-like domains feature a 
common initial conformational change, where the first β strand unfurls. Domains that lack 
their N-terminal β strands appear similar to one another, maintaining their native-like 
conformation under low forces. At intermediate forces, they unfold to a heterogeneous 
population of intermediate states similar to seven-stranded domains.  
Additionally, the effect of temperature versus mechanical stress on unfolding 
pathways has been the subject of much debate (146). The general hypothesis is that thermally 
induced and force-induced unfolding pathways are independent from one another since the 
thermal fluctuations are exerted on the protein globally, while the effect of mechanical force 
is localized and non-homogeneous. To examine whether the thermally and force-induced 
unfolding of filamin Ig-like domains are different from each other, we also perform thermal 
unfolding of three Ig-like domains, 14, 21, and 24. Interestingly, we find that thermally 
induced unfolding shares the same initial unfolding intermediate state as forced unfolding, 
where the first strand unfolds. This observation suggests that filamin evolved to feature the 
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intermediate state of unfolded N-terminal strand(s). Given the observation that the putative 
first strand of domain 20 interacts with domain 21 instead of forming a β sheet with the 
second strand, we propose that an N-terminal strand may act as a conformational switch that 
unfolds under stressed physiological conditions leading to exposure of cryptic binding sites, 
removing of native binding sites, and modulating the quaternary structure of domains. 
 
3.2 Materials and methods  
All-atom DMD   
 A detailed description of the DMD algorithm can be found elsewhere (149, 183). 
Briefly, interatomic interactions in DMD are governed by square-well potential functions. 
Neighboring interactions along the sequence (such as bonds, bond angles, and dihedrals) are 
modeled by infinitely deep square-well potentials to model the geometry of residues and 
peptide bonds. During a simulation, an atom’s velocity remains constant until a potential step 
is encountered, during which it changes instantaneously according to the laws of 
conservation of energy, momentum and angular momentum. Simulations proceed as a series 
of such collisions, with a rapid sorting algorithm employed at each step to determine the next 
collision. 
 The all-atom DMD method employs a united atom protein model, where heavy atoms 
and polar hydrogen atoms are explicitly modeled (149). We include van der Waals, solvation, 
and environment-dependent hydrogen bond interactions. For solvation, we adopt the 
Lazaridis-Karplus solvation model (184, 185) and use the fully-solvated conformation as the 
reference state. Due to the strong screening effect of solvent, distant charges have weak polar 
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interactions. For salt-bridges, we expect the hydrogen bonds to partially account for their 
polar interactions.  
 
Protein models  
As described in the introduction filamin A is composed of an ABD followed by 24 Ig-
like domains. Ig-like domains are seven-stranded β sandwich folds (Figure 3.1 A). Loops 
with conserved residues GPG and SPF bisect the first and last strands. We refer the resulting 
subdomains as A, A’, G’, G. Subdomain A forms a β sheet with B (A-B region) and in some 
domains A’ and G (A-G’ region) form a β sheet. We use the homology models of human 
filamin A Ig-like domains (Figure 3.1 A) that were derived from an earlier work (Kesner et 
al., submitted). Briefly, closest matching homology templates were derived from a structural 
alignment of homologous filamin domains in the protein data bank (PDB) (186). Insight II 
(Accelrys, CA) was then used to perform homology modeling of each filamin A Ig-like 
domain. Domain 16, 18 and 20; have only six complete strands since the best-match template 
lacks all (16), or sub-strand A (18, 20) of β strand A. 
Each model is validated using the sequence-structure compatibility score from the 
Verify-3d module of InsightII (Accelrys Inc.). This analysis measures the compatibility of 
modeled residues with their structural environment (154). Quality scores of greater than 0.1 
indicates valid structural models (154) and typical biochemical structures have a score of 1. 
The mean Verify-3d score obtained for Ig-like domain models was 0.89 with standard 
deviation 0.30. Overall, Ig-like domains have high quality scores indicative of their high 
accuracy. 
Following homology modeling, each structure is relaxed using 1000 steps of steepest 
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descent energy minimization as in AMBER(187) 9.0. In addition, each model is minimized 
using the Medusa modeling suite (150, 151, 188). 
 
 
 
Figure 3.1.  Critical force-induced unfolding parameters of filamin Ig-
like domains. (A) Seven-stranded Ig-like domain with subdomain termini 
and β strands A-G labeled. (B) Graph depicting the free energy landscape 
along the extension length as the reaction coordinate at different levels of 
constant-force pulling.  Fc is the critical unfolding force and xu is the 
distance to the center of the unfolding energy barrier. (C) Unfolding 
behavior of a domain pulled apart with a constant force (122.5 pN) is 
described by plotting the extension length as a function of time.   Replicates 
with differing initial velocities vary in their unfolding behavior. (D) A 
linear natural log plot of the pulling force versus mean first passage time.  
Fc is the critical unfolding force.  A linear fit of forces is shown for the 
barrier (left of Fc) and barrierless (right of Fc) regimes. (E) Critical 
unfolding forces observed for each domain. The error bars are determined 
as described in Methods. (F) Histogram of mean Fc. 
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Constant-force unfolding  
For each domain, we start the constant-force simulations from the homology-derived 
native state. The dimension of a cubic simulation box is 500 Å and the periodic boundary 
condition is used. We use an Anderson thermostat(189) to maintain constant temperature at 
270 Kelvin. Constant-force pulling is achieved by applying a discretized step-function with a 
constant energy jump, dE, at the distance step of dR (1 Å) between the N- and C-termini. The 
pulling force equals to dE/dR. For example, dE of 0.5 kcal/mol is equivalent to 
approximately 35 pN. The applied forces range from zero to 315 pN. From zero to 210 pN, 
we sample the force values with an interval of 17.5 pN. From 245 to 315 pN, the interval is 
35 pN. For each force, we perform 10-20 realizations of pulling simulations, each of which 
start with randomized velocities. We perform 10 simulations for pulling simulations at low 
forces (70 pN or less), since there is a low probability of unfolding during the simulation 
time. For higher forces, we perform 20 realizations. 
 
Derivation of critical unfolding forces   
Under external force F, the unfolding time under pulling forces can be approximated 
as . Here,  A is the Arrhenius prefactor, ΔG
‡
 is the zero force 
activation energy barrier, xu is the distance to the center of the activation energy barrier, 
and β is the inverse of kbT, where kb is the Boltzmann constant and T is the temperature. We 
use the mean first passage time (MFPT) of unfolding as the approximation of the unfolding 
time. We use 200 Å as the cutoff distance to assess whether a protein is unfolded. This cutoff 
was determined base upon observations that after an extension of 200 Å most domains lack 
metastable states, although the minimum full extent for an unfolded domain is 240 Å (Figure 
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3.2). If the protein has not unfolded within the maximum simulation time (one million time 
units), we use this time as the first passage time.  
We plot the ln(MFPT) versus force and obtain linear fits in the barrier and barrierless 
unfolding regions. The intersection of the two linear fits determines the critical force of 
unfolding (Fc). We use the error bar of the linear regression to estimate the error bar of the 
estimated critical forces with a simple Monte Carlo method. In each Monte Carlo step, linear 
lines constructed based on the Gaussian distribution of error bars (derived form the linear 
regression) is used to determine a new intersection. The mean and standard deviation of the 
critical unfolding force is derived from the set of intersections. 
 
Forced unfolding pathways analysis   
For each domain and each force, we combine trajectories of all realizations and 
compute the histogram of extension lengths. Gaussian curve fitting of the histogram is used 
to identify metastable states. Only the states that are present for more than 1% of the total 
simulation time are considered stable. To determine the representative structure of each 
metastable state, we first extract all conformations having extension length within the mean ± 
2 SD of the corresponding Gaussian fit. Then, we compute a contact frequency map for each 
extracted ensemble. Finally, we select the representative structure as the one that has the least 
contact distance from the average contact frequency of the ensemble.  
We characterize the unfolding pathway using a directed graph. The nodes of the graph 
are formed by the states identified from the extension length histogram and the edges are the 
transitions between the different states. Occupancy of each node corresponds to the number 
of conformations associated with that state normalized by the total number of conformations. 
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Edges have an associated transition probability determined by counting the number of 
transitions between a node and its neighbor and then dividing by total number of transitions 
to all its neighbors in the same direction. The graph representation of the unfolding pathway 
is visualized using Cytoscape (190).  
 
Thermal unfolding   
Equilibrium simulations are performed at a wide range of temperatures: 300, 330, 
360, 390, and 420 Kelvin. We use the percentage of native contacts, Q, to approximate the 
reaction coordinate. We define a contact when the distance between two Cβ atoms (Cα for 
Glycine) is less than 8.5 Å. We use a similar approach to identify the representative structure 
of each state, where the Q-value rather than the extension distance is used as the 
approximation of the reaction coordinate. To determine the localization of loss of contacts 
during thermal unfolding simulations we calculate a subdomain average Q-value. 
Subdomains are delineated based upon a strand-by-strand analysis of each Ig-like domain 
homology model. Average Q-values for an ensemble are obtained by dividing the marginal 
sum of native contacts from the residue-by-residue contact frequency map by the marginal 
native contacts from the reference structure contact map. 
 
 
3.3 Results 
We model constant-force unfolding by applying a pulling force between the Cα 
atoms of the N- and C-terminal residues (Materials and methods). The force is modeled by 
assigning a corresponding potential between the corresponding atom pair. For each force 
value, we perform 10-20 independent simulations with randomized initial velocities. Each 
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simulation lasts a million DMD time units. 
 
Computationally identified critical unfolding forces of filamin Ig-like domains agree 
with AFM experiments 
Most single domain proteins, such as the Ig-like domains in filamin, feature a two-
state folding/unfolding dynamics without external forces. At 270 K, a protein stays folded 
and its native state corresponds to the lowest energy state in the free energy landscape 
(Figure 3.1 B). Unfolding requires overcoming a free energy barrier (the folding/unfolding 
transition state) separating the folded and unfolded states, ΔG‡. The unfolding time is 
proportional to the exponential of ΔG‡/kBT. As the force (F) applied to the N- and C-termini 
of a protein increases, the unfolded states with large end-to-end extensions are favored 
(Figure 3.1 C), and the corresponding free energy barrier decreases (ΔG‡-Fxu (Figure 3.1 B)). 
Here, xu denotes the difference of end-to-end distances between the transition and native 
states. Assuming that xu does not change for different external forces, the natural logarithm of 
the unfolding time is linearly dependent on the external force. As the force reaches the 
critical value (Fc), the barrier will disappear and activation driven unfolding dynamics is 
reduced to barrierless unfolding. As a result, the dependence of the unfolding time with 
respect to the external force changes near the Fc (Figure 3.1 D). We estimate the critical 
unfolding forces based on the change of the scaling of the unfolding time with respect to 
external forces (see Methods). For each applied force, we compute the mean first passage 
time (MFPT) over 20 trajectories to estimate the unfolding time. We use a cutoff distance of 
200 Å to assess whether a protein is unfolded. We estimate the critical force as the crossover 
point in the plot of ln(MFPT) as a function of external forces (Figure 3.1 D). We compute the 
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critical unfolding forces for each domain (Figure 3.1 E). The mean critical unfolding force 
over all domains is 179±19 pN. We find that the distribution of Fc values features a peak 
around 155-180 pN with a long tail from 185-205 pN (Figure 3.1 F). Therefore, most of the 
Ig-like domains of filamin A can withstand the stretching forces up to 150 pN with a few 
domains being able to resist higher forces. For example, domains 6 (217±68 pN) and 14 
(238±36 pN) have Fc values greater than 205 pN. Our calculated critical forces are consistent 
with the experimental measurements (50-220 pN as identified by AFM pulling study of 
Filamin A) (16). 
Sequence alignment during the homology modeling of domains 16, 18, and 20 
suggested that these domains lack the N-terminal β strand of the canonical Ig fold. Such a 
deviation from the canonical Ig-like domain suggests a unique biological function for these 
domains. Interestingly, the absence of these structural features did not significantly change 
the mechanical stability of these domains with respect to other domains. The two domains, 
18 and 20, have Fc of 170±18 pN, and domain 16, has an Fc of 188±68 pN. These data 
suggest that the mechanical stability of Ig domains is independent of the N-terminal β strand 
and likely to be caused by sequence difference in the core of the protein.  
Recent in vitro pulling experiments on filamin-actin networks suggest that filamin A 
Ig-like domains are subjected to equilibrium forces up to 80 pN (145). Hence, we analyze the 
conformational changes of each of the 24 Ig-like domains under 35 and 70 pN of constant 
pulling force next (Forced unfolding pathways analysis materials and methods).  
 
Under the 35 pN pulling force, most filamin Ig-like domains remain in a native-like 
state with a few domains featuring intermediate conformations that could potentially 
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play a role in stress signaling   
We analyze the population of conformations of each Ig-like domain under the 35 pN 
pulling force, which we expect to be physiologically relevant. We find that most of the 
domains stay in their near-native conformations as shown for domain 21 (Figure 3.2 B). The 
average end-to-end extension of these conformations is increased by ~10 Å, compared to the 
extension length seen in zero force extension (Figure 3 A and B, Appendix A). This is the 
result of pulling out leading N-terminal residues (Figure 3.3), which make little contacts in 
the native state. The rest of the structure remains intact.  
 
 
 
 
 
 
Figure 3.2.  Equilibrium stable intermediate states of 
domains at 35 pN of constant-force pulling.  Histogram of 
extension lengths for domains 13 (A) and 21 (B). A 
representative conformation for each state is shown. The solid 
line represents the distribution from simulations at 0 pN pulling 
and the dotted line represents the distribution from simulations 
at 35 pN pulling.   
 
 
                                   
Figure 3.3. Loss of N-terminal contacts of 
domains pulled apart at 35 pN.  For each 
domains we measured the average change in 
contacts relative to native, for N-t β strands A 
and C-t β strand G of each domain forced to 
unfold at 35 pN of force. 
Domains 
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Interestingly, we find that at the 35 pN pulling force a few domains feature a partially 
unfolded intermediate state, in addition to a near-native conformation. This is exemplified by 
partially unfolded state of domain 13 (Figure 3.2 A), which has the interaction between 
strands A and B lost while maintaining A’-G region contacts (Figure 3.2 A; the 55 Å 
conformation). This conformation is analogous to changes hypothesized for TNI27 when it 
was pulled at much higher forces (124, 191). The loss of β-strand A contacts while other β 
strands are left intact is common to most of the intermediate states of these domains. We do 
observe one exception: domain 15 loses its entire β strand A (Figure 3.4). This major 
conformational shift occurs in a small number of ensembles and produces an extension 
length of ~86 Å (Figure 2 B, Appendix A). Thus, while several domains have a modest 
conformational shift pulled at the 35 pN force, at least one domain has a major 
conformational shift that could serve as a potential signal of relatively low levels of cellular 
stress. 
 
 
Figure 3.4. Domain 15 force-induced unfolding conformations at 35 pN.   
We observe two stable ensembles when domain 15 is forced to unfold at 35 pN.  
A highly populated ensemble with mean extension of 53 Å (top) (representative 
conformation), and a smaller population with mean extension of 75 Å (bottom).  
In this population, β strand A is formed from loop AB.   
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At 70 pN, filamin domains have a diverse set of metastable states. The unfolding 
pathway of all domains is initiated by the loss of contacts in the N-terminal β  strands   
Under 70 pN pulling force, all Ig-like domains undergo large conformational changes 
(Figure 3.5 and Figure 3 C, Appendix A). The most populated states are those with end-to-
end extension within 20 Å of native state, where β strands A and/or G has been pulled out 
slightly, leaving the remaining structure native-like (Figure 3.5). The stretched conformations 
with longer extensions (>20 Å) have one β strand sliding past another (Figure 3.5 A) or lose 
contacts between strand A’ and G (63 Å extension in Figure 3.5 B; and 72 Å extension in 
Figure 3.5 C). Interestingly, TNI27 is reported to have similar initial unfolding pathways 
which features loss A-B contacts, loss of contacts in the A'-G region, and then quickly 
unfolding (124, 191). However, at 70 pN stretching force filamin Ig-like domains do not 
traverse directly to the unfolded state, instead they get trapped in several metastable states 
(Figure 3 C, Appendix A). These states include domains in which strand A (130 Å extension 
in Figure 3.5 B) or strands A and B have been unfolded (150 Å extension in Figure 3.5 A, 
and 149 Å extension in 3.5 B) from the rest of the domain resulting in conformations such as 
a single β sheet (150 Å in Figure 3.5 A) or a β sandwich (149 Å in Figure 3.5 B). These 
conformations are analogous to those observed in the metastable intermediate of ddFLN4 
when unfolded using forces in the order of 60 pN(133, 134). Also, FN-III10 has been 
observed to lose N-terminal β strands when forced to unfold using ~100 pN (131, 137). 
Domain 21 has a proclivity to also lose β strand G entirely (Figure 3.5 B 149Å), which could 
potentially be related to its role in the previously mentioned interdomain conformation, 
involving domain 20. Most other domains only lose β-strands at the N-terminus. 
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The most stable domains at 70 pN unfolding force are 3, 9, and 22, which have 
metastable states close to that of their native state (extension length < 86Å). The frequent 
interconversion between intermediate states of these domains suggests a low energy barrier 
between successive extension length states (domain 3). Domains 1, 6, 12, 13, and 14 also 
feature the near-native state being highly populated. However, these domains also feature an 
intermediate state missing the N-terminal β strands. Interestingly, we find other domains (e.g. 
21) are fully unfolded using a force ~70 pN, suggesting a lesser stability of these domains. 
 
 
Figure 3.5. Equilibrium stable intermediate states of domains at 
70 pN of constant-force pulling. Histogram of extension lengths for 
domains 13 (A), 21 (B), and 23 (C) A representative conformation 
for each state is shown. The solid line represents the distribution 
from simulations at 0 pN pulling and the dotted line represents the 
distribution from simulations at 70 pN pulling.  
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Domains in the range 9 to 15 are considered secondary sites for binding actin, and having 
unusually stable domains in this range could be critical to the structural role of filamin in 
cells (62).  
We also find that the mechanical stability of some Ig-like domains does not depend 
entirely on N-terminal β strands. We modeled domains 16 (N-terminal residues up to and 
including β strand A’), 18 and 20 (N-terminal residues up to and including β A) lacking N-
terminal β strands (Kesner et al., submitted) as their templates lacked β strand integrity in 
this region. We find that at both 35 and 70 pN, these domains have similar unfolding 
pathways and metastable conformations as seven-stranded domains. Domain 20 maintains a 
highly populated native-like conformation featuring an A’-G region β sheet at 35 pN (Figure 
3.6) and an unfolding pathway where the most populated state is native-like at 70 pN similar 
to seven-stranded domains. Domain 18 at 35 pN features two metastable states and does not 
unfold entirely. The most populated state is a β barrel with few of the native contacts 
lost (Figure 3.6). However, domain 18 also features a lowly populated state with a 
conformation that has an unfurled N-terminal β strand B at 35 pN, thus making it somewhat 
distinct from seven-stranded domains in which we observe the unfolding of β strand B only 
at 70 pN. At 70 pN domain 18 has a similar unfolding pathway as that of domain 24, 
featuring highly populated intermediate states that have extension lengths much greater than 
that of their native states (Figure 3 C, Appendix A). Domain 16 features the greatest 
differences in the unfolding pathway compared to seven-stranded domains: it has an 
unfolding pathway that is distinct from that of domains 18 and 20 and most seven-stranded 
Ig-like domains unfolding from the C-terminus at 35 pN (Figure 3.6). However, domain 16 is 
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very stable because at 70 pN, its most populated state is a metastable and not the fully 
unfolded state. Thus, all three domains lacking N-terminal β strands are highly stable at 35 
and 70 pN of force, although domain 18 and 20 are more similar to each other than to domain 
16, which unfolds from the C-terminus. 
This systematic analysis of our in silico pulling studies of filamin Ig-like domains 
reveals metastable intermediate states as observed in AFM experiments. Our simulations are 
able to reproduce experimentally derived critical unfolding forces. The conformational 
changes of all the Ig-like domains feature a common intermediate state where the N-terminal 
strand is unfolded, which could play a role in the signaling pathway of cell responses to 
mechanical stress. Next, we study the thermally induced unfolding of the filamin domains to 
test whether the intermediate states observed in forced pulling are also observed in thermally 
induced unfolding pathways. We restrict our study to three Ig-like domains, 14, 21 and 24. 
These domains are selected due to distinct kinetic properties and biological significance: 
domain 14 has the highest critical force, domain 21 has well-characterized 
thermodynamics(180), and domain 24 is involved in dimerization (181). 
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Figure 3.6. Domains without N-terminal β  strands force-induced unfolding conformations at 35 
pN. Domain 16 lacks β strand A and A’.  Domains 18, and 20 lack β strand A.  Shown are stable 
conformations of these domains pulled apart at 35 pN.   Domain 16 has two stable conformations, a 
native-like fold and a conformation where β strand G is unfolded. Domain 18 has two stable 
conformations, a native-like fold and a second conformation where β strand A’ unfolds from β strand 
B. Domain 20 has a highly stable native-like fold. 
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Thermal unfolding of filamin Ig-like domains features a common initial unfolding of 
the N-terminal β  strand  
We perform equilibrium DMD simulations of Ig-like domains 14, 21 and 24 over a 
wide range of temperatures (300-420 K). We use the weighted histogram analysis method 
(WHAM)(149) to compute the specific heat (Figure 3.7 A). The highest peak in the specific 
heat corresponds to the unfolding transition. The shoulders in the specific heat plot suggest 
the existence of an intermediate state. Our results indicate that domain 14 and 21 have similar 
unfolding temperature of ~340 K. Domain 24 is the most stable of these domains with 
unfolding transition temperature ~10 degrees higher than either 14 or 21 (Figure 3.7 A). The 
increased stability of domain 24 is possibly the result of its well-characterized role in 
dimerization of filamin monomers (181). Domain 14 has a prominent shoulder at temperature 
~370 K that is absent in domain 21, suggesting the existence of a thermally stable 
intermediate state.  
To further investigate the conformational states of these domains, we use the fraction 
of native contacts (Q) as the approximation of the reaction coordination to analyze the 
conformational state at different temperatures (Figure 3.7 B). We also compute the Q-value 
of each of segments in the native state (Figure 3.1 A, 3.7 C). At the low temperature of 300 
K, all domains have near-native conformation with high Q-values (Figure 3.7 B). As the 
temperature increases to 330 K, we find domain 14 features two states, I1 and I2, while 
domains 21 and 24 have only one. We examine the Q-values of each secondary structure 
segment at 330 K (Figure 3.7 C). For domain 14 both states I1 and I2 have large losses in A-
B region contacts, I2 however has more contacts lost in A’, B and G than does I2. 
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Furthermore, the conformation in I1 is a closed β sandwich whereas the conformation of I2 is 
an open β sandwich (Supplementary Figure 5A). Thus it is likely that A’-G region contacts 
are involved in maintaining the closed conformation of I1. Domain 21 has lost significant 
amount of native contacts in both the N- and C-terminal β strands. Domain 24 loses contacts 
of mainly in β strand A. The existence of two states of domain 14 is consistent with the 
shoulder in the specific heat. At high temperature of 360 K, the most populated state of each 
domain is the unfolded conformation. Consistent with the high thermal stability, the β strands 
CDFG of domain 24 still retain partial native interaction at 360 K (Figure 3.7 C). 
 
Figure 3.7. Thermal unfolding of filamin domains. (A) Plot of the specific heat as a 
function of temperature for domains 14, 21, and 24 calculated using the WHAM.  
Representative conformations of the metastable states of domain 21 at temperatures 300, 
330 and 360 are also shown. (B) Histogram of Q-values for compiled replicated trajectories 
at each temperature (300, 330, 360 K) for domains 14, 21 and 24.  Metastable states of 
domain 21 at 330 K are labeled I1 and I2. (C) Average Q-value for metastable state for 
each subdomain (Figure 3.1 A) at each temperature (300, 330, 360 K).  
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Jiang et al., using an NMR based approach determined the unfolding temperature of 
domain 21 to be 319 K. They also reported that different filamin Ig-like domains have 
different thermal stabilities. Domain 19 and 17 are fully folded at 333 K while domain 21 is 
unfolded (180). They have also reported a partially unfolded fraction of domain 21 under 
mild conditions (298 K). It is possible that the differences between domains observed were 
the result of β strand A’s displacement that we observed in domain 21 in our simulations at 
330 K since the residue they used as a folding marker is adjacent to β strand A. Our results 
are quite distinct from those of other reported simulations of thermal unfolding of Ig-like 
domains. For example, Paci et al., simulated the unfolding of TNI27 at 450 K and found 
unfolding pathways in which the last strands to unfold were the terminal β strands (192). 
Given the high temperatures used, it is possible that these observations were the result of 
non-equilibrium simulations. 
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3.4 Discussion 
 Mounting experimental evidence suggests that filamin A molecules act not only as 
structural and mechanical proteins that cross-links F-actin fibrils, but also as scaffold proteins 
that play a critical role in cellular response to external mechanical stress (44, 45, 56, 58, 61, 
178). We hypothesize that conformational changes of filamin A due to mechanical stress are 
important for signaling, where stress-induced conformational changes can either disrupt 
existing interactions or introduce new interactions. We systematically studied the 
conformational dynamics of forced unfolding of filamin Ig-like domains using DMD. We 
developed a novel technique to derive the critical unfolding force from constant-force 
trajectories that is based upon finding the intersection between two unfolding regimes with 
respect to pulling forces. As a validation of our methodology, our computationally estimated 
forced unfolding dynamics of filamin A Ig-like domains agree with AFM experiments. For 
example, our simulation suggests the average critical unfolding force is 150-240 pN, which is 
consistent with the experimental measurements of 50-220 pN. Our analysis of the force-
induced unfolding trajectories suggests the existence of multiple intermediate states 
corresponding to partially unfolded β sandwich of Ig-like domains. Additionally, an 
intermediate state observed in the simulations common to most filamin A Ig-like domains is 
characterized by the unfolding of the first N-terminal β strand. This intermediate state is 
consistent with the intermediate state observed in the force-induced unfolding of D. 
discoideum filamin domain 4, 27 Ig-like domain of titin, and fibronectin type three domain 
10 (122-124, 131, 133, 135, 137, 191). Thus, our stretching simulations using all-atom DMD 
is able to recapitulate the conformational dynamics of Ig-like domains under force. 
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Our simulation results suggest that at low force (35 pN) most of the Ig-like domains remain 
in the native state with only a few domains featuring a weak population of a partially 
unfolded N-terminal strand. As the force increases (up to ~70 pN, which is close to the 
maximal forces observed in vivo) (193), we observe an increased population of intermediate 
states. Most of the domains still remain in their native or near-native conformations since 
these forces are still below the Fc. We find a large heterogeneity in both the population of the 
force-induced intermediate states and the transitions between them. However, we do find a 
common initial unfolding intermediate common to all Ig-like domains, where the N-terminal 
strand unfolds, similar to those observed in AFM experiments on TNI27 (123, 191).  
Studies with TNI27 have suggested that contacts within A’-G region are important for 
maintaining the stability of its metastable state (121). We observe a similar phenomenon in 
domain 20’s metastable states. However, the stability of other six-stranded domains appears 
to be independent of this region. Domain 18 loses A’-G region contacts during unfolding, 
and yet does not completely unfold. Also, domain 16 which lacks subdomain A’, has a 
similar critical unfolding force as other domains. These three domains might not be 
representative of all domains since in their native-like state they are stable absent N-terminal 
β strands. On the other hand both thermally and forced unfolding pathways of most seven-
stranded Ig-like domains feature metastable states that lack any A’ contacts. Thus, it is likely 
the A’-G region plays a minor role in filamin Ig-like domain stability. 
Our results from thermal unfolding of Ig-like domains suggest that there is no 
correlation between thermal and mechanical stability. For example, domain 14, which has the 
highest critical unfolding force, is thermally less stable than domain 24. However, there does 
appear to be a correlation between thermal unfolding and force-induced unfolding pathways. 
  
  79 
In the case of both low force unfolding and low temperature thermal unfolding, unfolding is 
mostly initiated with the loss of contacts in N-terminal β strands. In the few cases where we 
observe initiation of forced unfolding at both the N- and C- terminus (domain 21) we also 
observe loss of contacts at both termini due to thermal denaturation. Thus, as evidenced by 
both thermal and force-induced unfolding pathways, Ig domains of filamin have a similar 
initial unfolding intermediate state. This similarity may be the result of evolutionary 
optimization of filamin due to its role as a structural and scaffold protein. 
Filamins interact with a wide range of cell signaling proteins, and the conformational 
changes upon stress can either disrupt or promote these interactions. Additionally, the 
exposure of partially unfolded strands can promote modifications such as phosphorylation, 
which in turn can activate downstream signaling pathways. Therefore, we postulate that 
intermediates with their N-terminal strands unfolded could be involved in the cellular 
response to external mechanical stress. Further experimental studies are required to verify 
this hypothesis. 
 
3.5 Conclusion 
Stress levels in cells can be very large, especially in the cortex where the amount of 
stress depends on its compliance to the surrounding surface (194). In this study, we find that 
under forces between 150–240 pN filamin domains readily unfold. However, under lower 
forces, domains unfold in stages producing a heterogeneous population of metastable states 
lacking N-terminal β strands. Our simulations of thermal unfolding reveal similar metastable 
states. Furthermore, we observe that the domains that were modeled lacking all or part of the 
N-terminal β strand (16, 18 and 20) have similar forced unfolding characteristics as canonical 
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Ig-like domains. Thus, it appears that the stability of Ig-like domains is independent of N-
terminal β strands. Domain 20 has been shown to have an N-terminal β strand playing an 
inhibitory role for protein-protein interactions involving filamin A (93). Since domain 18 has 
a similar forced unfolding pathway as domain 20, it is possible that β strand A of domain 18 
has a similar biological function. Moreover, it is possible that unraveling of N-terminal β 
strands leads to interdomain interactions, that may produce the inhibitory behavior, as 
observed by Lad et al.(93). Other possible ramifications to having exposed β strands include 
exposure of cryptic binding sites or post translational modification sites; higher degree of 
connectivity between filamin monomers as more β strand edges are exposed; a higher 
turnover rate as more residues are exposed to potential cleavage; forming of new F-actin 
structures (cross-links vs. bundles); attraction of heat shock proteins to refold domains as 
stress increases; allowing Ig-like domains to more quickly refold back to their native fold 
when stresses and then are relaxed; or allowing multiple domains to fold properly(195). For 
example, proteomic screens revealed two phospho-serines (S1081 and S1084) (91, 92) in the 
loop between β strands A and B of domain 9 of filamin A. Thus, we postulate that the stress-
induced unfurling of the N-terminal β strands of filamin domains could play an important 
cellular role as a conformational switch. 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
Chapter 4 
Discussion 
4.1 Summary 
 In Chapters 2 and 3 we analyzed the functional aspects of filamin from two different 
perspectives. In Chapter 2 we analyzed the functional divergence of filamin isoforms. During 
this analysis we develop a structural model of filamin A; a phylogenetic analysis of 
invertebrate, invertebrate chordate, and vertebrate filamin; and an evolutionary trace (ET) of 
the vertebrate filamin family, which we use to observe the divergence of individual filamin 
residues in a spatial and temporal context. In Chapter 3 we analyzed the mechanical function 
of filamin A. During this analysis we used molecular dynamics to perform single-molecule 
force-induced unfolding experiments. For each Ig-like domain, we observe critical unfolding 
forces and low force (35-70 pN) unfolding pathways. We also examined the effect of thermal 
unfolding on Ig domains.  
 In each analysis we used novel techniques. In our ET analysis, we create an all-atom 
homology model of a filamin A monomer. We used this model to observe spatial and 
temporal divergence of family members in the context of a quaternary structure. We also 
used a highly constrained version of ET to restrict our results to functionally informative 
sites. In our analysis of the mechanical properties of filamin Ig domains, we use Discrete 
Molecular Dynamics (DMD) as the molecular dynamics technique. To our knowledge, this 
technique has not been applied previously to study the mechanical properties of proteins. The 
efficiency of DMD allows us to perform multiple replicated simulations instead of a single 
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simulation using traditional molecular dynamics. In addition, we developed a new method of 
determining critical unfolding force from constant force trajectories. This method is based 
upon finding the intersection between two unfolding regimes with respect to pulling forces. 
Our results are in agreement with published data and suggest the validity of our techniques.  
 
Validation of results  
 Our all-atom model has dimensions and architecture of filamin that are similar to 
those observed in electron micrographs (18, 62, 161). Recent electron micrographs and 
experimental data (62) suggest that filamin A has two distinct architectural regions, one 
consisting a linear sequence of domains (rod 1) and the other a compact group of domains 
(rod 2). This linear region is similar to the high-resolution crystal structure of ddFilamin 
domains 4-6 (PBD ID 1WLH) (155). The compact region results from two domains, 18 and 
20, which lack β strand A. As further validation of the modeling of the compact region, our 
pulling data suggest that Ig domains 18 and 20 are stable, even though they lack β strand A.  
 Our phylogenetic study of vertebrate filamin suggests that the three isogenes of 
filamin (A, B, and C) originated from a single ancestral gene that existed prior to the advent 
of vertebrates, and that this gene is also the progenitor of extant urochordate filamin. If this 
model is correct, then some functions shared among vertebrate isoforms of filamin should 
also be common to extant urochordate filamin. All three isoforms of filamin interact with all 
β1 integrin family members through a highly ancestral binding surface on domain 21 (21, 47, 
86). In addition, each isoform has a low number of class-distinctive sites in domain 21, an 
indication of lack of isoform-specific functional divergence. Therefore, we posit that the 
interaction of filamin with integrins predates vertebrate evolution. Support for this hypothesis 
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comes from humans and Ciona transcripts of integrins (Figure 4.1) that have high sequence 
similarity in the filamin-binding region. The highest sequence similarity is between human 
β3 integrin and Ciona β1 integrin.  
 Validation of our ability to identify sites critical for filamin functional divergence 
comes from a recent study of the interaction of FILGAP with filamin domain 23. We identify 
a class-distinctive residue on each of filamin B and filamin C that subsequently was shown to 
be critical for the distinct binding of filamin A to FILGAP(175). We also identify sites that 
suggest isoforms have diverged in their ability to regulate their interactions with binding 
partners. In vitro studies confirm this possibility (5, 49). These binding partners include 
migfilin and integrins. Furthermore, we find many instances in which functionally divergent 
sites co-localize with disease-causing mutations, indicating biochemical functional 
significance. 
 Our pulling results are also commensurate with several reports. The average critical 
unfolding force for all Ig domains overlaps with reported atomic force microscopy (AFM) 
results — 150-240 pN (DMD) vs. 50-220 pN (AFM) (16). In addition, the stable 
intermediates we observe in filamin Ig-like are similar to the intermediates ddFilamin4, 
TNI27, and FN-III10. Also similar are the N-terminal unfoldings of β strands. In addition, the 
 
 
Figure 4.1. Alignment of β1 
integrin family members in the 
filamin A binding region. Top four 
sequences are human (h), rest are 
from Ciona (c) (1, 2). 
Alignment: /Users/barrykesner/Documents/Disertation/figures/ciona.fasta
Seaview [blocks=10 fontsize=14 A4] on Sat Jun 13 21:00:18 2009 
      1
hB1A  NPIYKSAVTT VVNP
hB2   NPIYKSAVTT VVNP
hB3   NPLYKEATST FTNI
hB7   NPLYKSAITT TINP
cB1   NPIFKKATST FKNP
cB2   NPIFEEASTR FENP
cB3   NPIFEEASTR FENP
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range of forces we observe in the unfolding of filamin Ig-like domains (35-70 pN) is very 
similar to the range observed in FN-III10 and ddFilamin4 (Table 3). Our thermal unfolding 
results for domain 21 (330-360 K) are also similar to reported results (319 K) (180).  
 
Functional divergence of isoforms as scaffold proteins 
 We also hypothesize that our distinctive residues may contribute to the evolution of 
isoform-distinctive behavior in several ways. These include variable specificity in binding; 
differential regulation of binding of adhesion proteins, effector proteins, and F-actin; and 
potentially distinctive modulation of inter-domain structure. For example, over 35% of 
distinctive residue changes in filamin A and C involve changes to or from S/T residues, while 
only 11% of distinctive changes in B involve S/T residues. Thus, filamin isoforms are likely 
to have different roles in signaling as phosphoproteins. From our analysis of the mechanical 
properties of Ig domains, it is possible that some of S/T are exposed only on force-induced 
unfolding. For example, in filamin A, proteomic screens revealed two phospho-serines in the 
loop between β strands A and B of domain 9 (91, 92). Thus, force-induced conformational 
changes may lead to differential scaffolding activity. 
 
Functional divergence of isoforms as mechanical proteins 
 Since filamin isoforms play critical roles as mechanical proteins (18), we also 
hypothesize that some of the distinctive residues observed may mediate isoform-specific 
structural characteristics. These characteristics may translate into isoform-distinct structural 
roles in cells. For example, in Chapter 2 we identify a cluster of distinctive sites in ABD CH 
2 that co-localize with mutations causing skeletal disorders. The function of CH 2 is not 
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currently understood; however, the ABD CH 2 has been reported to modulate the affinity of 
filamin for F-actin (169). Thus, we posit that distinctive changes in the ABD may also 
modulate the affinity of filamin isoforms for F-actin. The resulting ramifications of these 
distinctive changes could potentially be related to isoform-distinct roles in differentiation (55, 
57). Further experimental testing of the distinctive residues is required to understand their 
isoform-specific role. 
 Several missense mutations along rod 1 of filamin A and B also cause skeletal 
disorders, whose etiology is unknown. One hypothesis is that mutations interfere with the 
structure of filamin. Since these missense mutations are not buried, it is difficult to 
understand how they could pertain to structure. However, ET analysis can identify residues 
that are involved in the structural divergence of isoforms. The structural divergence of 
mechanical proteins may be related to how their domains respond to force-induced 
unfolding. Since some distinctive residues in rod 1 co-localize near disease mutations, it is 
possible that these mutations could interfere with force-induced unfolding. In a model 
presented by Gehler et al., (57) filamin acts as a stress sensor in extracellular matrix (ECM) 
compliance matching (matching of ECM stiffness to intracellular stress), leading to cellular 
differentiation. The failure of filamin Ig domains to unfold properly under force may cause 
filamin to fail as a stress sensor, leading to disease. 
 
Importance of dual evolutionary constraints on filamin function 
 We hypothesize that filamin Ig-like domains hold unique structural properties 
because in both thermal- and forced-unfolding pathways, unfolding is initiated by the 
unraveling of N-terminal β strands. This is an unexpected result (192) since thermal 
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denaturation can affect all bonds of a domain, whereas denaturation is localized during 
forced unfolding. Therefore, we speculate that filamin domains have evolved in this 
particular way because of dual constraints on filamin, as both a scaffold protein and a 
mechanical protein. Under stress, N-terminal β strand unfolding may protect binding of 
ligands to the CD face. Currently, the only structurally characterized binding method is by 
anti-parallel β sheet extension of β strand C (5). Alternatively, unfolding of N-terminal β 
strands may allow filamin to act as a, mechanosensory scaffold protein, by disrupting or 
creating binding surfaces. For example, the HIV-1 receptor was identified as binding to 
filamin A Ig domain 10, β strand G (196), and its interaction with filamin would likely be 
disrupted by β strand A unfolding. 
 
Importance of heterogeneity of domain characteristics 
 In Chapter 3, we observe heterogeneity in domain mechanical characteristics. We 
hypothesize that this heterogeneity can allow filamin to act as a multiport switch that is tuned 
to the forced unfolding of other domains. Gehler et al. reported, that Filamin A is a 
component of the acromyosin contractility pathway (Figure 1.5), which has a role in ECM 
remodeling (57). Critically, the ECM is composed of fibronectin (FN), which can unravel the 
N-terminus of its domains under forces (Table 3) similar to those used to unfold filamin (137, 
197). Since filamin and FN are in the same stress pathway, we postulate that they can 
partially unfold simultaneously, leading to coordinated efficient inside-out and outside-in 
signaling. One way to test this hypothesis would be to simulate unfolding of pairs of 
individual fibronectin and filamin Ig domains to see if they cooperatively unfold. Identified 
pairs can then be tested biochemically, either by over-expression or deletion studies. The 
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observation by Lu et al. (55), that differentiation of proliferating chondrocytes in the growth 
plate is delayed in filamin B-null mutant chondrocytes, could potentially be explained by 
inefficient signal transduction due to loss of filamin B. 
 
4.2 Future directions and conclusions 
 We have analyzed the functional divergence of filamin isoforms, and determined sites  
we feel are important for their divergences. Thus, our work provides the basis for site-
directed mutagenesis studies. In addition, our analysis of force-induced unfolding of Ig-like 
domains suggests that the filamin molecules act as a mechanosensory scaffold proteins when 
cells are placed under stress. One way to test this hypothesis is to use an immunogenic 
approach, by creating an antibody to a force-induced conformation. We have also suggested 
that disease mutations may disrupt switch-like function. To test this hypothesis, we can 
perform forced-unfolding unfolding simulation on mutant Ig-like domains. Our model also 
suggests a reason for splice variants lacking hinge 1. We posit that lacking hinge 1 would 
make filamin more sensitive to stress. Thus hinges may control stress tolerance. A cell may 
require this tolerance to protect itself from premature differentiation(21).  
   Thus, viewing filamins as both a structural protein and a stress-induced dynamic 
scaffold can potentially shed light on the commonality among disease mutations as well as 
the roles of distinct isoforms in acromyosin contractility, mechanoprotection, and cell 
differentiation. Thus, our findings may lead to our understanding of the etiology of many 
diseases (Table 2) including prolapsed valve (198), muscular dystrophy, and Alzheimer’s 
disease (199).  
The work contained within this dissertation extended our knowledge of the function 
of filamin. While most experimentalists have analyzed filamin from the perspective of their 
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particular protein, we have taken a top-down approach, allowing us to identify, without bias, 
residues critical to the function of filamin. We have also identified mechanical properties of 
filamin Ig domains which we postulate enable filamin to sense stress. The methods we 
employ in this dissertation can be used to understand the function of many protein families, 
from coronins to viral coat proteins. Since studying the biochemistry of proteins under stress 
is a difficult task, our work will forge the way for others to use the tools we have developed. 
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Appendix A  
Extra figures 
A 
 
Figure 1. Multiple sequence alignment used to obtain homology model templates of filamin domains.  
(A) Alignment of homologous actin-binding domains (ABD) from plectin (PDB ID 
1SH5), dystrophin (PDB ID 1DXX), α-actinin 1 (PDB ID 2EYI), α-actinin 3 (PDB ID 
1WKU), human filamin A, human filamin B, and human filamin C. Muscle specific α-
actinin 3 is used as a template to model filamin A’s ABD. (B) Alignment of target and 
template (asterisk (*)) filamin Ig-like domains. Excluded are predicted Ig-like domains 
that have close homologs in the PDB (e.g., we do not include the sequence IgFLNa12 
along with IgFLNb12 (PDB ID 2DIC)). We show all isoforms of domain 16 for 
comparison. 
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Figure 2. Conservation within domains is bi-modal. The number of residues in each domain that are 
conserved to the common ancestor across filamin isoforms. N-terminal domains 1-16 alternate between the two 
conservation modes and have a mean of 62±9%. C-terminal domains 17-24, have a mean are more highly 
conserved overall (mean 71±8%). The histogram, right is bimodal, with a mode at ~70% and a mode at ~55%. 
Individual highly conserved domains are CH 1 (88%), IgFLNa21 (84%) and IgFLNa22 (79%). Domains with 
the least conservation include 5, 8, 10, 11 (~50%).  
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A B 
C 
Figure 3. Force-induced unfolding 
pathways of filamin Ig-like domains.  
Each filamin domain is subjected to 
constant opposing force acting on the Nt 
and Ct Cα atoms for 1 x 106 time units 
(t.u.). The last 0.5 x 106 t.u., are examined 
for stable intermediates (circles) using a 
histogram of extension lengths (x).  
Minimum occupancy of a state is ~ 5%.   
Directed graphs represent unfolding 
pathways.  Circle density represents 
trajectory occupancy, arrow density 
represents transition probability, circle 
with bar represents unfolded. Numbers to 
left of state represents mean x of stable 
intermediate. (A) At 0 pN pulling force,  
most domains are native (~ 40 Å), shorter 
states are from floppy N-terminus. (B) At 
35 pN pulling force most domains have a 
native pulled state is ~ 47 Å x.  However, 
some domains have a less populated state 
at ~ +10 Å.    Domains lacking β strand A 
(16, 18, 20) and A’ (16) are less stable, 
having secondary intermediates with larger 
jumps (20-30 Å), or unfold. (C) At 70 pN 
pulling force, domains have varying 
unfolding pathways. Some domains are 
stable close to their native-like x (e.g., 3, 9, 
22), while others fully unfolded.  Stable 
pathways tend to cycle between the first 
two metastable states.  Pathways having a 
third state, with x in the range 140-170 Å; 
have partially unfolded ensembles, which 
lack N-terminal β strands.   Domains 16, 
18, and 20 appear similar to 7 β stranded 
counterparts.  
 
 
0 pN 35 pN 
70 pN 
= 100 % occupancy 
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Appendix B 
Additional tables 
Domain (target) Template(s) PDB ID Method Verify 
score 
ABD Human a actinin 3 closed conformation 1wku X-ray 0.75 
Ig-like     
1 hsIgFLNb9 
hsIgFLNc14 
2di9 
2e9j 
NMR 
NMR 
0.72 
2 hsIgFLNc14 2e9j NMR 1.12 
3 hsIgFLNb19 2di9 NMR 1.42 
4 hsIgFLNa17 2bp3 X-ray 0.87 
5 hsIgFLNc14 
ddFLN5 from ddFLN4-6 
2e9j 
1wlh 
NMR 
X-ray 
0.88 
6 hsIgFLNc14 
ddFLN5 from ddFLN4-6 
2d9j 
1wlh 
NMR 
X-ray 
0.88 
7 hsIgFLNc14, 
ddFLN5 from  ddFLN4-6 
2d9j 
1wlh 
NMR 
X-ray 
0.97 
8 hsIgFLNb10 
hsIgFLNb19 
ddFLN5 from ddFLN4-6 
2dia 
2di8 
1wlh 
NMR 
NMR 
X-ray 
0.73 
9 hsIgFLNb9 2di9 NMR 1.14 
10 hsIgFLNb10 2dia NMR 1.01 
11 hsIgFLNb13 2dj4 NMR 0.51 
12 hsIgFLNc12 2dic NMR 0.89 
13 hsIgFLNb13 2dj4 NMR 0.58 
14 hsIgFLNc14 2d9j NMR 0.85 
15 hsIgFLNb15 2dmb NMR 0.72 
16 hsIgFLNc10 
hsIgFLNc16 
2dia 
2d7n 
NMR 
NMR 
0.64 
17 hsIgFLNa17 2bp3 X-ray 0.98 
18 hsIgFLNb18 2dmc NMR 0.11* 
19 hsIgFLNb19 2di8 NMR 1.17 
20 hsIgFLNb18 2dmc NMR 0.65 
21 hsIgFLNb19 2di8 NMR 1.13 
22 hsIgFLNc22 2dlg NMR 1.25 
23 hsIgFLNc23 2d7q NMR 1.45 
24 hsIgFLNc24 1v05 X-ray 1.04 
Table 1. Filamin domain homology templates 
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 Ig domain 
pairs 
Linker 
length 
Short linker 
1-2 4 375NKSQ379 
2-3 2 476GA477 
3-4 2 572TE573 
4-5 6 664RDAPQD669 
5-6 3 764GAG766 
6-7 3 867EPS869 
7-8 3 966SPS969 
8-9 3 1062VAP1064 
9-10 3 1155VPC1157 
10-11 3 1250EPA1253 
11-12 3 1350TEG1352 
12-13 3 1443HDV1445 
13-14 3 1540LPT1542 
14-15 3 1637VPT1638 
16-17 2 1861DY1862 
18-19 4 2039SQSE2042 
20-21 5 2231GPLGE2235 
21-22 5 2226ASPSG2330 
Table 2. Linkers between Ig-like domains 
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Protein name ID  
Human filamin A  NP_001447.2 
Canis familiaris filamin A  ENSCAFT00000031079 
Mus musculus filamin A  ENSMUST00000052678 
Rattus norvegicus filamin A  ENSRNOT00000012796 
Xenopus tropicalis filamin A  ENSXETT00000031243 
Danio rerio filamin A  ENSDART00000046261 
Tetraodon nigroviridis filamin A  GSTENT00008691001 
Takifugu rubripes filamin A  NEWSINFRUT00000159596 
Human filamin B  NP_001448.2 
Canis familiaris filamin B  ENSCAFT00000012236 
Mus musculus filamin B  ENSMUST00000052678 
Rattus norvegicus filamin B  ENSRNOT00000012796 
Xenopus tropicalis filamin B ENSXETT00000018970 
Danio rerio filamin B ENSDART00000086028 
Tetraodon nigroviridis filamin B  GSTENT00012499001 
Takifugu rubripes filamin B  NEWSINFRUT00000147431 
Human filamin C NP_001449.3 
Canis familiaris filamin C  ENSCAFT00000002504 
Mus musculus filamin C  ENSMUST00000065090 
Rattus norvegicus filamin C XP_342654.2 
Xenopus tropicalis filamin C  ENSXETT00000032738 
Danio rerio filamin C  ENSDART00000073442 
Tetraodon nigroviridis filamin C  GSTENT00029754001 
Takifugu rubripes filamin C  NEWSINFRUT00000181322 
Ciona intestinalis, Ciona savignyi ENSCINT00000006732 (42,48)/ 
ENSCING00000003272 (gene), 
ENSCSAVT00000017772/ 
ENSCSAVG00000010354(gene) 
Strongylocentrotus purpuratu XP_784715.2 
Anopheles gambiae AGAP004335-PA 
Table 3. Filamin protein sequences 
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FLN domain Isoform  
common  
ancestral  
residues 
Range  
(filamin A) 
Residues 
ABD    
CH 1 97 40-151 112 
CH 2 75 168-264 97 
Ig-like    
1 62 279-374 96 
2 52 379-475 97 
3 67 478-71 94 
4 90 574-663 90 
5 45 670-763 94 
6 67 767-866 100 
7 64 870-965 96 
8 46 969-1061 93 
9 67 1065-1154 90 
10 46 1158-1249 92 
11 48 1253-1349 97 
12 62 1352-1442 91 
13 55 1446-1539 94 
14 67 1543-1636 94 
15 56 1640-1744 105 
16 53 1771-1860 90 
17 66 1863-1952 90 
18 44 1968-2039 72 
19 64 2044-2134 91 
20 48 2159-2230 72 
21 77 2236-2325 90 
22 72 2331-2420 90 
23 62 2427-2516 90 
24 62 2553-2646 94 
 
Table 4. Filamin domain ancestral conservation 
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Isoform Domain Ancestral Conservation1 Distinctive Modifications2  
(Teleostei period) 
A CH 1    High c Low 
 CH 2 High High 
 12 High High 
 14 High   No - 
 17 High High 
 18 Low    High + 
 21   High i Low 
B CH 1    High c   Low - 
 CH 2 High High 
 6 High High 
 12 High High 
 15 Low High 
 16 Low High 
 17 High High 
 18 Low    High + 
 19 High High 
 20 High Low - 
 21 High i Low 
 22 High Low 
 23 High Low 
C CH 1 High c Low 
 CH 2 High Low 
 6 High Low 
 9 High  No - 
 11 High High + 
 12 High Low 
 16 High    High + 
 17 High  No - 
 19 High Low 
 21   High i  No - 
Table 5. Filamin domain isoform-distinctive content 
 
1 High/Low ancestral conservation implies greater than or less than 0.6 percent ancestral. 
2 High/Low distinctive residue implies per domain (A: > 6 / < 2  B: > 8 / < 4  C: > 6 / < 3). 
c, i Most Ancestral Residues for Isoform (c = CH domain, I = Ig-like domain) 
+/- Most/Least Distinctive Residues. 
consecutive distinctive/ancestral 
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